<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1523" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1523/" /><meta name="ncbi_pagename" content="22q11.2 Deletion Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>22q11.2 Deletion Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="22q11.2 Deletion Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2013/02/28" /><meta name="citation_author" content="Donna M McDonald-McGinn" /><meta name="citation_author" content="Beverly S Emanuel" /><meta name="citation_author" content="Elaine H Zackai" /><meta name="citation_pmid" content="20301696" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1523/" /><meta name="citation_keywords" content="22q11.2DS" /><meta name="citation_keywords" content="22q11.2DS" /><meta name="citation_keywords" content="Velocardiofacial Syndrome" /><meta name="citation_keywords" content="Autosomal Dominant Opitz G/BBB Syndrome" /><meta name="citation_keywords" content="Cayler Cardiofacial Syndrome" /><meta name="citation_keywords" content="DiGeorge Syndrome" /><meta name="citation_keywords" content="Conotruncal Anomaly Face Syndrome" /><meta name="citation_keywords" content="Sedlackova Syndrome" /><meta name="citation_keywords" content="T-box transcription factor TBX1" /><meta name="citation_keywords" content="TBX1" /><meta name="citation_keywords" content="22q11.2 Deletion Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="22q11.2 Deletion Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Donna M McDonald-McGinn" /><meta name="DC.Contributor" content="Beverly S Emanuel" /><meta name="DC.Contributor" content="Elaine H Zackai" /><meta name="DC.Date" content="2013/02/28" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1523/" /><meta name="description" content="Individuals with 22q11.2 deletion syndrome (22q11.2DS) have a range of findings including the following:" /><meta name="og:title" content="22q11.2 Deletion Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Individuals with 22q11.2 deletion syndrome (22q11.2DS) have a range of findings including the following:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1523/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/gr_22q11deletion/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1523/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE89B3D4E0413EF10000000001B700C6.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1523_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1523_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cah/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/dupl22q11/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1523_"><span class="title" itemprop="name">22q11.2 Deletion Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: 22q11.2DS</div><p class="contrib-group"><span itemprop="author">Donna M McDonald-McGinn</span>, MS, CGC, <span itemprop="author">Beverly S Emanuel</span>, PhD, and <span itemprop="author">Elaine H Zackai</span>, MD, FACMG.</p><a data-jig="ncbitoggler" href="#__NBK1523_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1523_ai__"><div class="contrib half_rhythm"><span itemprop="author">Donna M McDonald-McGinn</span>, MS, CGC<div class="affiliation small">Children's Hospital of Philadelphia<br />Philadelphia, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.pohc.liame@nnigcm" class="oemail">ude.pohc.liame@nnigcm</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Beverly S Emanuel</span>, PhD<div class="affiliation small">Division of Human Genetics and Molecular Biology<br />Children's Hospital of Philadelphia<br />Philadelphia, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.nnepu.dem.liam@ylreveb" class="oemail">ude.nnepu.dem.liam@ylreveb</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Elaine H Zackai</span>, MD, FACMG<div class="affiliation small">Children's Hospital of Philadelphia<br />Philadelphia, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.pohc.liame@iakcaz" class="oemail">ude.pohc.liame@iakcaz</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">September 23, 1999</span>; Last Update: <span itemprop="dateModified">February 28, 2013</span>.</p><p><em>Estimated reading time: 38 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="gr_22q11deletion.Summary" itemprop="description"><h2 id="_gr_22q11deletion_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Individuals with 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a> (22q11.2DS) have a range of findings including the following:</p><ul><li class="half_rhythm"><div>Congenital heart disease (74% of individuals), particularly conotruncal malformations (tetralogy of Fallot, interrupted aortic arch, ventricular septal defect, and truncus arteriosus)</div></li><li class="half_rhythm"><div>Palatal abnormalities (69%), particularly velopharyngeal incompetence, submucosal cleft palate, bifid uvula, and cleft palate</div></li><li class="half_rhythm"><div>Characteristic facial features (present in the majority of individuals of northern European heritage)</div></li><li class="half_rhythm"><div>Learning difficulties (70%-90%)</div></li><li class="half_rhythm"><div>An immune deficiency (regardless of the clinical presentation) (77%)</div></li></ul><p>Additional findings include the following:</p><ul><li class="half_rhythm"><div>Hypocalcemia (50%)</div></li><li class="half_rhythm"><div>Significant feeding and swallowing problems; constipation with or without structural gastrointestinal anomalies (intestinal malrotation, imperforate anus, and Hirschsprung disease)</div></li><li class="half_rhythm"><div>Renal anomalies (31%)</div></li><li class="half_rhythm"><div>Hearing loss (both conductive and sensorineural)</div></li><li class="half_rhythm"><div>Laryngotracheoesophageal anomalies</div></li><li class="half_rhythm"><div>Growth hormone deficiency</div></li><li class="half_rhythm"><div>Autoimmune disorders</div></li><li class="half_rhythm"><div>Seizures (<a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> or associated with hypocalcemia)</div></li><li class="half_rhythm"><div>CNS anomalies including tethered cord</div></li><li class="half_rhythm"><div>Skeletal abnormalities (scoliosis with or without vertebral anomalies, clubbed feet, polydactyly, and craniosynostosis)</div></li><li class="half_rhythm"><div>Ophthalmologic abnormalities (strabismus, posterior embryotoxon, tortuous retinal vessels, scleracornea, and anophthalmia)</div></li><li class="half_rhythm"><div>Enamel hypoplasia</div></li><li class="half_rhythm"><div>Malignancies (rare)</div></li></ul><p>Developmental delay (in particular delays in emergence of language), intellectual disability, and learning differences (non-verbal learning disability where the verbal IQ is significantly greater than the performance IQ) are common.</p><p>Autism or autistic spectrum disorder is found in approximately 20% of children and psychiatric illness (specifically schizophrenia) is present in 25% of adults; however, attention deficit disorder, anxiety, perseveration, and difficulty with social interactions are also common.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a> is diagnosed in individuals with a submicroscopic deletion of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22 detected by fluorescence in situ hybridization (<a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>), multiplex ligation-dependent probe amplification (MLPA), or <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA). At present, fewer than 5% of individuals with clinical findings of the 22q11.2 deletion syndrome have normal routine <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> studies and normal results on FISH testing; however, this figure may change as individuals with atypical or nested deletions within the DGCR (DiGeorge chromosome region) but not including the area encompassing the N25 or TUPLE FISH probes are identified using array-based or MLPA technologies.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Multidisciplinary team approach (which may include any combination of the following: allergy, audiology, cardiology, cardiac surgery, child development / psychology, dental, endocrine, ENT, feeding, gastroenterology, general pediatrics, general surgery, immunology, clinical genetics, neurology, neurosurgery, ophthalmology, orthopedics, otolaryngology, plastic surgery, psychiatry, pulmonary, rheumatology, speech, and urology tailored to the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's specific needs. Calcium supplementation and referral to an endocrinologist for hypocalcemia and thyroid monitoring; specific strategies (modification of spoon placement when eating; treatment for gastroesophageal reflux and gastrointestinal dysmotility) for feeding difficulties; educational intervention and speech therapy/introduction of sign language therapy beginning at diagnosis because of risk for delays. Growth hormone deficiency is treated as in the general population. Immune deficiency requires aggressive treatment of infections; rarely, prophylactic antibiotics, IVIG therapy, or thymic transplantation are required. Early diagnosis and intervention for psychiatric illnesses improve long-term prognosis.</p><p><i>Prevention of secondary complications:</i> Immunization of infants who have lymphocyte abnormalities with live vaccines is not recommended; reevaluate immune status in childhood before giving live vaccines; antibody studies to assess results of immunizations are warranted; irradiated blood products are recommended until normalization of the immune system can be confirmed; serum ionized calcium concentration should be measured pre- and postoperatively to avoid hypocalcemic seizures; consider assessment of carotid arteries prior to surgical procedures involving the pharynx; consider possible effects on speech prior to adenoidectomy; consider assessment of cervical spine anomalies prior to hyperextension of the neck during surgical procedures/athletic pursuits; consider pre- and postoperative sleep studies when performing pharyngeal procedures; consider assessment of platelet volume and function prior to surgical procedures.</p><p><i>Surveillance</i>: Follow up as needed on a "system by system" basis, but including routine reassessment of serum ionized calcium and thyroid studies; reevaluation of immunologic status prior to live virus vaccines; annual complete blood count and differential; ophthalmologic evaluation prior to school age; evaluation of nasal speech quality; audiology evaluation prior to school enrollment; surveillance for scoliosis; routine dental care; regular speech, language and developmental assessments to provide appropriate remediation.</p><p><i>Agents/circumstances to avoid</i>: Carbonated drinks and alcohol consumption may exacerbate hypocalcemia. Caffeine intake may contribute to or worsen anxiety.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a> is a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion-syndrome/">contiguous gene deletion syndrome</a> inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. About 93% of probands have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> deletion of 22q11.2 and 7% have inherited the 22q11.2 deletion from a parent. Offspring of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a 50% chance of inheriting the 22q11.2 deletion. Prenatal testing for pregnancies at increased risk based on family history is possible if the diagnosis has been confirmed in an affected family member and for pregnancies not known to be at increased risk in which <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease and/or other associated abnormalities (e.g., cleft palate, polydactyly, diaphragmatic hernia, renal anomalies, and polyhydramnios) have been detected by ultrasound examination.</p></div></div><div id="gr_22q11deletion.GeneReview_Scope"><h2 id="_gr_22q11deletion_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="gr_22q11deletion.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1523/table/gr_22q11deletion.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gr_22q11deletion.Td_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gr_22q11deletion.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22q11.2 Deletion Syndrome: Included Phenotypes</th></tr></thead><tbody><tr><td headers="hd_h_gr_22q11deletion.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>DiGeorge syndrome</div></li><li class="half_rhythm"><div>Velocardiofacial syndrome</div></li><li class="half_rhythm"><div>Conotruncal anomaly face syndrome</div></li><li class="half_rhythm"><div>Autosomal dominant Opitz G/BBB syndrome</div></li><li class="half_rhythm"><div>Sedlackova syndrome</div></li><li class="half_rhythm"><div>Cayler cardiofacial syndrome</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#gr_22q11deletion.Nomenclature">Nomenclature</a>.</p></div></dd></dl></div></div></div></div><div id="gr_22q11deletion.Diagnosis"><h2 id="_gr_22q11deletion_Diagnosis_">Diagnosis</h2><div id="gr_22q11deletion.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a> (22q11.2DS) is suspected in individuals with a range of findings including the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">Congenital heart disease (particularly conotruncal defects)</div></li><li class="half_rhythm"><div class="half_rhythm">Palatal abnormalities (especially velopharyngeal insufficiency [VPI])</div></li><li class="half_rhythm"><div class="half_rhythm">Hypocalcemia</div></li><li class="half_rhythm"><div class="half_rhythm">Immune deficiency</div></li><li class="half_rhythm"><div class="half_rhythm">Learning difficulties (especially a nonverbal learning disability, with a greater than ten-point split between the verbal intelligence quotient [VIQ] and the performance intelligence quotient [PIQ]: VIQ&#x0003e;PIQ)</div></li><li class="half_rhythm"><div class="half_rhythm">Characteristic facial features</div><div class="half_rhythm"><b>Note:</b> See the National Human Genome Research Institute (NHGRI) <a href="https://research.nhgri.nih.gov/atlas/condition/22q11-2-deletion-syndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Atlas of Human Malformation Syndromes</a> (scroll to <b>ATLAS IMAGES</b>) for photographs of individuals with 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a> from diverse ethnic backgrounds.</div></li></ul><p>Less frequently seen functional differences:</p><ul><li class="half_rhythm"><div>Severe dysphagia</div></li><li class="half_rhythm"><div>Growth hormone deficiency</div></li><li class="half_rhythm"><div>Autoimmune disease (thrombocytopenia, juvenile rheumatoid arthritis, Grave's disease, vitiligo, neutropenia, hemolytic anemia)</div></li><li class="half_rhythm"><div>Hearing loss (sensorineural and conductive)</div></li><li class="half_rhythm"><div>Psychiatric illness</div></li><li class="half_rhythm"><div>Autism</div></li></ul><p>Other important structural anomalies contributing to diagnosis:</p><ul><li class="half_rhythm"><div>Skeletal findings: pre- and postaxial polydactyly of the hands, postaxial polydactyly of the feet, supernumerary ribs, hemivertebrae, and craniosynostosis (coronal, lambdoidal)</div></li><li class="half_rhythm"><div>Genitourinary tract anomalies: renal agenesis, hydronephrosis, multicystic/dysplastic kidneys, duplicated kidney, horseshoe kidney, absent uterus, hypospadias, inguinal hernia, and cryptorchidism</div></li><li class="half_rhythm"><div>Laryngotracheoesophageal abnormalities: vascular ring, laryngeal web, laryngotracheal malacia, and subglottic stenosis</div></li><li class="half_rhythm"><div>Ophthalmologic findings: tortuous retinal vessels, ptosis, posterior embryotoxon, sclerocornea, coloboma, cataract, anophthalmia, and strabismus</div></li><li class="half_rhythm"><div>CNS abnormalities: cerebellar atrophy, polymicrogyria, enlarged sylvian fissures, neural tube defects, tethered cord, unprovoked seizures, and asymmetric crying facies</div></li><li class="half_rhythm"><div>Gastrointestinal anomalies: anteriorly placed/imperforate anus, esophageal atresia, jejunal atresia, accessory spleens, umbilical hernia, diaphragmatic hernia, intestinal malrotation, and Hirschsprung disease</div></li><li class="half_rhythm"><div>Preauricular tags and/or pits</div></li></ul><p>Neoplasms:</p><ul><li class="half_rhythm"><div>Hepatoblastoma, renal cell carcinoma, Wilms tumor, and neuroblastoma</div></li></ul></div><div id="gr_22q11deletion.Testing"><h3>Testing</h3><p><b>Cytogenetic testing.</b> The syndrome most often results from a three million-<a class="def" href="/books/n/gene/glossary/def-item/base-pair/">base pair</a> (Mb) <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> region 22q11.2 that is flanked by low copy number repeats (LCRs), labeled A-D (see <a href="#gr_22q11deletion.Molecular_Genetics">Molecular Genetics</a> ). The deletion is caused by a non-allelic meiotic <a class="def" href="/books/n/gene/glossary/def-item/recombination/">recombination</a> event during spermatogenesis or oogenesis (see <a class="figpopup" href="/books/NBK1523/figure/gr_22q11deletion.F1/?report=objectonly" target="object" rid-figpopup="figgr22q11deletionF1" rid-ob="figobgr22q11deletionF1">Figure 1</a>).</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figgr22q11deletionF1" co-legend-rid="figlgndgr22q11deletionF1"><a href="/books/NBK1523/figure/gr_22q11deletion.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figgr22q11deletionF1" rid-ob="figobgr22q11deletionF1"><img class="small-thumb" src="/books/NBK1523/bin/gr_22q11deletion-Image001.gif" src-large="/books/NBK1523/bin/gr_22q11deletion-Image001.jpg" alt="Figure 1. . 22q11." /></a><div class="icnblk_cntnt" id="figlgndgr22q11deletionF1"><h4 id="gr_22q11deletion.F1"><a href="/books/NBK1523/figure/gr_22q11deletion.F1/?report=objectonly" target="object" rid-ob="figobgr22q11deletionF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">22q11.2DS is thought to result from non-allelic homologous recombination due to the presence of segmental duplications (SD) which flank the region and lead to aberrant interchromosomal exchanges. These SDs, referred to as A, B, C, and D here, but as LCR22-2, <a href="/books/NBK1523/figure/gr_22q11deletion.F1/?report=objectonly" target="object" rid-ob="figobgr22q11deletionF1">(more...)</a></p></div></div><p>The most common <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, present in 85% of individuals, extends from A to D and includes <i>TBX1</i> (<a class="figpopup" href="/books/NBK1523/figure/gr_22q11deletion.F2/?report=objectonly" target="object" rid-figpopup="figgr22q11deletionF2" rid-ob="figobgr22q11deletionF2">Figure 2</a>)<i>,</i> a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deemed responsible for typically associated features, in particular conotruncal cardiac anomalies. The remaining 15% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have atypical "nested" deletions. To date, atypical deletions include A-B, B-D, or C-D deletions. These latter deletions are being identified using higher-resolution techniques including <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) or multiplex ligation-dependent probe amplification (MLPA). Of the atypical deletions, 34% do not include the A-B region. The commercially available fluorescence in situ hybridization (<a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>) probes, N25 and TUPLE, along with <i>TBX1</i>, are located within A-B; therefore, the atypical deletions that do not include A-B are not identifiable using the commercially available FISH probes (<a class="figpopup" href="/books/NBK1523/figure/gr_22q11deletion.F2/?report=objectonly" target="object" rid-figpopup="figgr22q11deletionF2" rid-ob="figobgr22q11deletionF2">Figure 2</a>).</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figgr22q11deletionF2" co-legend-rid="figlgndgr22q11deletionF2"><a href="/books/NBK1523/figure/gr_22q11deletion.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figgr22q11deletionF2" rid-ob="figobgr22q11deletionF2"><img class="small-thumb" src="/books/NBK1523/bin/gr_22q11deletion-Image002.gif" src-large="/books/NBK1523/bin/gr_22q11deletion-Image002.jpg" alt="Figure 2. . The majority of affected individuals (85%) have a large (3-Mb) deletion encompassing approximately 40 genes; a subset of individuals have a smaller atypical or &quot;nested&quot; deletion." /></a><div class="icnblk_cntnt" id="figlgndgr22q11deletionF2"><h4 id="gr_22q11deletion.F2"><a href="/books/NBK1523/figure/gr_22q11deletion.F2/?report=objectonly" target="object" rid-ob="figobgr22q11deletionF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">The majority of affected individuals (85%) have a large (3-Mb) deletion encompassing approximately 40 genes; a subset of individuals have a smaller atypical or "nested" deletion. Reprinted from McDonald-McGinn &#x00026; Zackai [2008] with permission from <a href="/books/NBK1523/figure/gr_22q11deletion.F2/?report=objectonly" target="object" rid-ob="figobgr22q11deletionF2">(more...)</a></p></div></div><p>A small percentage (&#x0003c;1%) of individuals with clinical findings of 22q11.2DS have <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangements involving 22q11.2, such as a <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> between chromosome 22 and another autosome.</p><div id="gr_22q11deletion.Molecular_Genetic_Testi"><h4>Molecular Genetic Testing</h4><p><b>Gene.</b> Deletion of genes within the DiGeorge <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> region (DGCR) is the only genetic abnormality known to be associated with 22q11.2DS [<a class="bk_pop" href="#gr_22q11deletion.REF.driscoll.1992.924">Driscoll et al 1992</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.wilson.1992.957">Wilson et al 1992</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.desmaze.1993.663">Desmaze et al 1993</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.driscoll.1993.813">Driscoll et al 1993</a>].</p><p><b>Clinical testing</b></p><p><b><a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>.</b> The two probes commercially available for 22q11.2 FISH analysis are TUPLE1 and N25. The detection rate of FISH analysis using either probe is thought to be equivalent. However, FISH with either probe is not sensitive enough to detect smaller deletions (&#x0003c;40 kb) within 22q11.2. Most deletions are now being identified by the use of CMA or MLPA, either of which will detect the smaller deletions missed by FISH. These studies will not detect pathogenic variants in any of the genes within the deleted region, however.</p><p>Note: The probe ARSA, which hybridizes to <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> 22q13.3, may also be used in testing, but only for control purposes.</p><p><b>Duplication/<a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> analysis</b> is testing that identifies deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. The 2.54-Mb A-D common deletion can be detected by any molecular method that determines the copy number of genomic sequences within the deleted region (see <a class="figpopup" href="/books/NBK1523/table/gr_22q11deletion.T.molecular_genetic_tes/?report=objectonly" target="object" rid-figpopup="figgr22q11deletionTmoleculargenetictes" rid-ob="figobgr22q11deletionTmoleculargenetictes">Table 1</a>, footnote 2). Either whole-genome or targeted approaches can be applied (see <a href="#gr_22q11deletion.Molecular_Genetics">Molecular Genetics</a> for details of the deleted region):</p><ul><li class="half_rhythm"><div><b>Chromosomal microarray (CMA) technologies</b> are the most appropriate test to identify the 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is nonspecific and often performed as part of the evaluation of developmental delay or intellectual disability. CMA can detect many <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> abnormalities that may be causal. CMA analysis using arrays of BACs, oligonucleotides, or SNPs (single-nucleotide polymorphisms) can detect the 2.54-Mb deletion in a proband. The ability to size the deletion depends on the type of microarray used and the density of probes in the 22q11.2 region.</div></li><li class="half_rhythm"><div><b>Targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> analysis.</b> Targeted methods including for example, <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> and MLPA, can be used for rapid diagnosis if the syndrome is suspected clinically or for confirmation of the deletion after CMA analysis. Targeted approaches can also be used for evaluating relatives of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> for presence of the deletion.</div></li></ul><p>Note: Whether or not it is possible to size the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> depends on the number and distribution of probes in the 22q11.2 region. The deletion cannot be sized using a single <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> probe (as is customary in commercial laboratories).</p><div id="gr_22q11deletion.T.molecular_genetic_tes" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in the 22q11.2 Deletion Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1523/table/gr_22q11deletion.T.molecular_genetic_tes/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gr_22q11deletion.T.molecular_genetic_tes_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gr_22q11deletion.T.molecular_genetic_tes_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Chromosome Region</th><th id="hd_h_gr_22q11deletion.T.molecular_genetic_tes_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_gr_22q11deletion.T.molecular_genetic_tes_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variants Detected&#x000a0;<sup>1</sup></th><th id="hd_h_gr_22q11deletion.T.molecular_genetic_tes_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Detection Frequency by Test Method&#x000a0;<sup>2</sup></th></tr></thead><tbody><tr><td headers="hd_h_gr_22q11deletion.T.molecular_genetic_tes_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">DGCR</td><td headers="hd_h_gr_22q11deletion.T.molecular_genetic_tes_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>3</sup>: <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a></td><td headers="hd_h_gr_22q11deletion.T.molecular_genetic_tes_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deletion of 22q11.2 DGCR</td><td headers="hd_h_gr_22q11deletion.T.molecular_genetic_tes_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~95%</td></tr><tr><td headers="hd_h_gr_22q11deletion.T.molecular_genetic_tes_1_1_1_2" rowspan="2" colspan="1" scope="row" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>3</sup>: <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> or targeted analysis</td><td headers="hd_h_gr_22q11deletion.T.molecular_genetic_tes_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">The common A-D <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a></td><td headers="hd_h_gr_22q11deletion.T.molecular_genetic_tes_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">85%</td></tr><tr><td headers="hd_h_gr_22q11deletion.T.molecular_genetic_tes_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Atypical/nested deletions</td><td headers="hd_h_gr_22q11deletion.T.molecular_genetic_tes_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="gr_22q11deletion.TF.1.1"><p class="no_margin">See <a href="#gr_22q11deletion.Molecular_Genetics">Molecular Genetics</a> for information on variants.</p></div></dd><dt>2. </dt><dd><div id="gr_22q11deletion.TF.1.2"><p class="no_margin">The ability of the test method used to detect a variant that is present in the indicated region</p></div></dd><dt>3. </dt><dd><div id="gr_22q11deletion.TF.1.3"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA; included in the variety of methods that may be used are: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd></dl></div></div></div><p><b>Interpretation of test results</b></p><ul><li class="half_rhythm"><div><b>Deletion analysis.</b> Depending on the type of initial testing, validation of the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> by an independent method could be warranted. If high-density <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> microarray platforms have been used for the identification of the deletion, validation of the deletion may not be necessary, as it is unlikely that more than 50-100 adjacent targets show an abnormal copy number by chance.</div></li></ul></div></div><div id="gr_22q11deletion.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b> requires detection of a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the q arm of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22, within the 11.2 region.</p><ul><li class="half_rhythm"><div>Most deletions are detected by <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) analysis performed as part of the evaluation of developmental delay or intellectual disability.</div></li><li class="half_rhythm"><div>If the 22q11.2 microdeletion is suspected based on the clinical features, a targeted technique (e.g., <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>, MLPA) can be employed for rapid diagnosis; however, both CMA and MLPA have a higher <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> for detection of atypical deletions and will allow for determination of the size of the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>.</div></li></ul><p><b>Prenatal diagnosis and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> (PGD)</b> for pregnancies known to be at risk require prior identification of the 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> and/or demonstration that a parent carries a balanced or unbalanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement involving 22q11.2.</p></div></div><div id="gr_22q11deletion.Clinical_Characteristic"><h2 id="_gr_22q11deletion_Clinical_Characteristic_">Clinical Characteristics</h2><div id="gr_22q11deletion.Clinical_Description"><h3>Clinical Description</h3><p>Findings in 250 individuals (48% male; 52% female) with 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a> (DS) are summarized below [<a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.1999.11">McDonald-McGinn et al 1999</a>]. In unpublished data on an additional 750 individuals evaluated through a large multidisciplinary 22q11 deletion syndrome center, the percentages for the following findings remain the same [Author 2012, unpublished data].</p><p><b>Heart.</b> Congenital heart defects are present in 74% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and are the major cause of mortality (&#x0003e;90% of all deaths) in this diagnosis [<a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.2001.23">McDonald-McGinn et al 2001</a>]. The most frequent anomalies are conotruncal defects of the outflow tract, as shown in <a class="figpopup" href="/books/NBK1523/table/gr_22q11deletion.T.cardiac_findings_in_2/?report=objectonly" target="object" rid-figpopup="figgr22q11deletionTcardiacfindingsin2" rid-ob="figobgr22q11deletionTcardiacfindingsin2">Table 2</a>. Of note, a subset of affected individuals are found to have dilated aortic root [<a class="bk_pop" href="#gr_22q11deletion.REF.john.2009.939">John et al 2009</a>]. The natural history of affected individuals who have aortic root dilatation is unknown but under investigation.</p><div id="gr_22q11deletion.T.cardiac_findings_in_2" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Cardiac Findings in 222 Individuals with 22q11.2 Deletion Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1523/table/gr_22q11deletion.T.cardiac_findings_in_2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gr_22q11deletion.T.cardiac_findings_in_2_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cardiac Finding</th><th id="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">% of Affected Individuals</th></tr></thead><tbody><tr><td headers="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Tetralogy of Fallot (TOF)</td><td headers="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20%</td></tr><tr><td headers="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Interrupted aortic arch (IAA)</td><td headers="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">13%</td></tr><tr><td headers="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ventricular septal defect (VSD)</td><td headers="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14%</td></tr><tr><td headers="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Truncus arteriosus (TA)</td><td headers="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6%</td></tr><tr><td headers="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vascular ring</td><td headers="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5.5%</td></tr><tr><td headers="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Atrial septal defect</td><td headers="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3.5%</td></tr><tr><td headers="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">VSD; ASD</td><td headers="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4%</td></tr><tr><td headers="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Other&#x000a0;<sup>1</sup></td><td headers="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10%</td></tr><tr><td headers="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_gr_22q11deletion.T.cardiac_findings_in_2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">24%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin"><a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.b">McDonald-McGinn et al [2010b]</a></p></div></dd><dt>1. </dt><dd><div id="gr_22q11deletion.TF.2.1"><p class="no_margin">Hypoplastic left heart syndrome; pulmonary valve stenosis; double outlet right ventricle; bicuspid aortic valve; heterotaxy/A-V canal, transposition of the great vessels; <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> right pulmonary artery atresia; aortic root dilatation; aberrant subclavian arteries</p></div></dd></dl></div></div></div><p><b>Palate.</b> Sixty-nine percent of individuals with <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> 22q11.2 have a palatal abnormality (<a class="figpopup" href="/books/NBK1523/table/gr_22q11deletion.T.palatal_findings_with/?report=objectonly" target="object" rid-figpopup="figgr22q11deletionTpalatalfindingswith" rid-ob="figobgr22q11deletionTpalatalfindingswith">Table 3</a>). The most common, velopharyngeal incompetence (VPI), may be a structural problem (short palate), a functional problem (hypotonia of the velophayrngeal musculature), or a combination of the two. Submucosal cleft palate and/or a bifid uvula are also fairly prevalent, whereas overt cleft palate and cleft lip/palate are less frequently observed. Often children initially diagnosed with deletion 22q11.2 because of a cardiac defect are subsequently found to have unrecognized but clinically significant VPI [<a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.1997a.99">McDonald-McGinn et al 1997a</a>]. It is important to note that the reported incidence of palatal abnormalities varies widely, depending on numerous factors including the reporting technique, the diligence with which the diagnosis is sought, the age at which the individual is evaluated, and the inherent ascertainment bias of any single center [<a class="bk_pop" href="#gr_22q11deletion.REF.kirschner.2005">Kirschner 2005</a>]. About 17% of persons have no palatal involvement.</p><div id="gr_22q11deletion.T.palatal_findings_with" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Palatal Findings with 22q11.2 Deletion Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1523/table/gr_22q11deletion.T.palatal_findings_with/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gr_22q11deletion.T.palatal_findings_with_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gr_22q11deletion.T.palatal_findings_with_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Palatal Finding</th><th id="hd_h_gr_22q11deletion.T.palatal_findings_with_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">% of Affected Individuals</th></tr></thead><tbody><tr><td headers="hd_h_gr_22q11deletion.T.palatal_findings_with_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Velopharyngeal incompetence (VPI)</td><td headers="hd_h_gr_22q11deletion.T.palatal_findings_with_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">27%</td></tr><tr><td headers="hd_h_gr_22q11deletion.T.palatal_findings_with_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Submucosal cleft palate (SMCP)</td><td headers="hd_h_gr_22q11deletion.T.palatal_findings_with_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">16%</td></tr><tr><td headers="hd_h_gr_22q11deletion.T.palatal_findings_with_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Overt cleft palate</td><td headers="hd_h_gr_22q11deletion.T.palatal_findings_with_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11%</td></tr><tr><td headers="hd_h_gr_22q11deletion.T.palatal_findings_with_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bifid uvula</td><td headers="hd_h_gr_22q11deletion.T.palatal_findings_with_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%</td></tr><tr><td headers="hd_h_gr_22q11deletion.T.palatal_findings_with_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cleft lip/cleft lip and palate&#x000a0;<sup>1</sup></td><td headers="hd_h_gr_22q11deletion.T.palatal_findings_with_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2%</td></tr><tr><td headers="hd_h_gr_22q11deletion.T.palatal_findings_with_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Infantile VPI&#x000a0;<sup>2</sup></td><td headers="hd_h_gr_22q11deletion.T.palatal_findings_with_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8%</td></tr><tr><td headers="hd_h_gr_22q11deletion.T.palatal_findings_with_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Need follow-up/too young to assess adequately&#x000a0;<sup>3</sup></td><td headers="hd_h_gr_22q11deletion.T.palatal_findings_with_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14%</td></tr><tr><td headers="hd_h_gr_22q11deletion.T.palatal_findings_with_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_gr_22q11deletion.T.palatal_findings_with_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">From <a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.1999.11">McDonald-McGinn et al [1999]</a></p></div></dd><dt>1. </dt><dd><div id="gr_22q11deletion.TF.3.1"><p class="no_margin">Either unilateral or bilateral</p></div></dd><dt>2. </dt><dd><div id="gr_22q11deletion.TF.3.2"><p class="no_margin">"Infantile VPI" or occult submucosal cleft palate diagnosed by history (nasal regurgitation and frequent otitis media), physical examination, or nasendoscopy (to detect incomplete closure of the velopharyngeal mechanism during crying and swallowing) in children too young to provide an adequate speech sample for definitive diagnosis</p></div></dd><dt>3. </dt><dd><div id="gr_22q11deletion.TF.3.3"><p class="no_margin">No overt abnormality, but children too young to provide an adequate speech sample</p></div></dd></dl></div></div></div><p><b>Feeding.</b> About 36% of children have significant feeding difficulties, often severe dysphagia requiring nasogastric tube feedings and/or gastrostomy tube placement. Feeding difficulties are independent of cardiac defects and palatal anomalies. Further evaluation of such children often reveals a preponderance of nasopharyngeal reflux, prominence of the cricopharyngeal muscle, abnormal cricopharyngeal closure, and/or diverticulum. Thus, the underlying feeding problem in many children appears to be dysmotility in the pharyngoesophageal area, which is derived from the third and fourth pharyngeal pouches.</p><p>Abnormal swallowing, with or without aspiration, may be erroneously attributed to palatal or cardiac abnormalities, rather than to dysphagia related to dysmotility and abnormality of the orophayrngeal and cricoesophageal swallowing phase. Aspiration should be considered a possible cause for respiratory compromise or recurrent pulmonary infections and reactive airway disease [<a class="bk_pop" href="#gr_22q11deletion.REF.eicher.2000.158">Eicher et al 2000</a>]. Constipation is a chronic feature in the majority of individuals. In addition, structural anomalies such as imperforate anus, intestinal malrotation, intestinal non-rotation, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> diaphragmatic hernia, esophageal atresia, tracheoesophageal fistula, Hirschsprung disease, and feeding difficulties secondary to a vascular ring have all been reported and can contribute to significant feeding and swallowing problems and in some instances to constipation [<a class="bk_pop" href="#gr_22q11deletion.REF.digilio.1999.137">Digilio et al 1999</a>; <a class="bk_pop" href="#gr_22q11deletion.REF.kilic.2003.e21">Kilic et al 2003</a>; D McDonald-McGinn 2010, unpublished data].</p><p><b>Immune function.</b> Immunodeficiency occurs as a result of thymic hypoplasia. Impaired T-cell production is the primary defect because the role of the thymus is to support the maturation of T cells. T-cell functional defects and antibody defects are less common and are secondary to the T-cell production abnormality [<a class="bk_pop" href="#gr_22q11deletion.REF.sullivan.2004.505">Sullivan 2004</a>].</p><p>Compared to control individuals without the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, newborns with the 22q11.2DS have significantly fewer cells of thymic lineage; however, improvement in T-cell production occurs over time. In one study, children with the most significant deficiencies in T-cell production improved most in the first year of life [<a class="bk_pop" href="#gr_22q11deletion.REF.sullivan.1999.906">Sullivan et al 1999</a>]. Thus, individuals with slight decreases in T-cell numbers typically have normal defenses against pathogens [<a class="bk_pop" href="#gr_22q11deletion.REF.sullivan.2004.505">Sullivan 2004</a>].</p><p>In a study of immune function in 60 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children over age six months, 77% were considered to be immunodeficient regardless of their clinical presentation. Sixty-seven percent had impaired T-cell production, 19% had impaired T-cell function, 23% had humoral defects, and 13% had IgA deficiency [<a class="bk_pop" href="#gr_22q11deletion.REF.smith.1998.415">Smith et al 1998</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.sullivan.1998.141">Sullivan et al 1998</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.sullivan.2004.505">Sullivan 2004</a>].</p><p>Additional phenotypic features associated with 22q11.2DS such as aspiration pneumonia, palatal dysfunction, and gastroesophageal reflux can all contribute to recurrent infection, especially in persons with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease. Furthermore, dysphagia can lead to poor nutrition which further impairs cellular immunity. Thus, older children and adults do in fact continue to have infections, including 25%-33% with recurrent sinusitis or otitis media and 4%-7% with recurrent lower respiratory infections [<a class="bk_pop" href="#gr_22q11deletion.REF.jawad.2001.715">Jawad et al 2001</a>]. However, despite these issues, very few school-aged children require active management for their immunodeficiency [<a class="bk_pop" href="#gr_22q11deletion.REF.sullivan.2004.505">Sullivan 2004</a>].</p><p>Immunoglobulin levels are usually normal in individuals with the 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a>, although subtle immunoglobulin abnormalities may be noted. Hypogammaglobulinemia present in the first year of life usually resolves and hypergammaglobulinemia may occur after age five. Although the majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have normal antibody function and antibody avidity, some have functional antibody defects. Those with recurrent sinopulmonary infections frequently have immunoglobulin abnormalities, in particular impaired antibody responses to pneumococcal polysaccharide vaccine [<a class="bk_pop" href="#gr_22q11deletion.REF.gennery.2002.422">Gennery et al 2002</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.sullivan.2004.505">Sullivan 2004</a>].</p><p>Autoimmune disease in 22q11.2DS is common. However, it does not correlate with severe T-cell dysfunction and it includes a range of pediatric diseases. Autoimmune cytopenias and juvenile rheumatoid arthritis (JRA) appear to be the most common and may occur 20-100 times more frequently than in the general population. JRA is often polyarticular and may be difficult to manage. Autoimmune thyroid disease and other autoimmune abnormalities have also been described and it is likely that the T-cell defect acts synergistically with other predisposing factors (e.g., major histocompatibility complexes) to cause autoimmune disease. Selective IgA deficiency may occur in up to 10% of individuals with a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, and seems to be particularly common in those with autoimmune problems including JRA [<a class="bk_pop" href="#gr_22q11deletion.REF.kawame.2001.892">Kawame et al 2001</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.sullivan.2004.505">Sullivan 2004</a>].</p><p><b>Parathyroid function.</b> Hypocalcemia is present in 17%-60% of persons with 22q11.2DS and is typically most serious in the neonatal period. Calcium homeostasis typically normalizes with age, although recurrence of hypocalcemia in later childhood and adulthood has been reported during illness and/or puberty or during pregnancy. In some instances, children receiving ongoing care for infantile hypocalcemia may not be diagnosed with 22q11.2DS until school age, while at least one otherwise asymptomatic adult came to attention following onset of hypoparathroidism in the fourth decade [<a class="bk_pop" href="#gr_22q11deletion.REF.kapadia.2008.224">Kapadia et al 2008</a>; M Eagen, personal communication].</p><p><b>Craniofacial.</b> Craniofacial findings include auricular abnormalities, nasal abnormalities, "hooded eyelids," ocular hypertelorism, cleft lip and palate, asymmetric crying facies, and craniosynostosis [<a class="bk_pop" href="#gr_22q11deletion.REF.gripp.1997.290">Gripp et al 1997</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.2001.23">McDonald-McGinn et al 2001</a>]. However, the presence of these features as well as other facial findings, such as a long face and malar flatness, is variable. In fact, some individuals offer no clues to their underlying diagnosis based on their facial features, especially persons of African-American heritage [<a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.1996.525">McDonald-McGinn et al 1996</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.2005.242">McDonald-McGinn et al 2005</a>].</p><p><b>Eyes.</b> A prospective evaluation for ocular abnormalities in 33 individuals revealed hooding of the upper lids (41%), ptosis (9%), hooding of the lower lids (6%), epicanthal folds (3%), and distichiasis (abnormal growth of lashes from the orifices of the meibomian glands) (3%). Other findings included posterior embryotoxon (69%), isolated corneal nerves (3%), sclerocornea (3%), deep iris crypts (10%), tortuous retinal vessels (58%), small optic nerves (7%), and tilted discs (3%). Strabismus was observed in 13% and amblyopia in 6%. While posterior embryotoxon was observed in 12%-32% of controls, the incidence in individuals with 22q11.2DS was almost as high as that seen in <a href="/books/n/gene/alagille/">Alagille syndrome</a> (89%) [<a class="bk_pop" href="#gr_22q11deletion.REF.krantz.1997.152">Krantz et al 1997</a>]. The incidence of astigmatism, myopia, and hyperopia was comparable to that in the general population. A small number of persons have cataracts and colobomas [<a class="bk_pop" href="#gr_22q11deletion.REF.forbes.2007.179">Forbes et al 2007</a>]; anophthalmia has recently been observed in a very small subset of individuals [Author, unpublished data].</p><p><b>Ear, nose, and throat.</b> Ear abnormalities include overfolded or squared off helices; cupped, microtic, and protuberant ears; preauricular pits or tags, and narrow external auditory meati. A prominent nasal root, bulbous nasal tip, hypoplastic alae nasae, and a nasal dimple/bifid nasal tip are common [<a class="bk_pop" href="#gr_22q11deletion.REF.gripp.1997.290">Gripp et al 1997</a>]. Stridor resulting from vascular ring, laryngomalacia, and laryngeal web, laryngeal atresia, and subglottic stenosis can occur. Chronic otitis media and chronic sinusitis are common. Sensorineural and conductive hearing loss have both been reported. Incidents of trachea-esophageal fistula and esophageal atresia have also been observed [M Digilio 1999, unpublished data].</p><p><b>Central nervous system.</b> Although the majority of individuals with 22q11.2DS have a history of hypotonia in infancy and learning disabilities [<a class="bk_pop" href="#gr_22q11deletion.REF.moss.1995.a42">Moss et al 1995</a>], specific neurologic manifestations are uncommon. Microcephaly has been reported in nearly 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in some studies [<a class="bk_pop" href="#gr_22q11deletion.REF.kobrynski.2007.1443">Kobrynski &#x00026; Sullivan 2007</a>] but in the authors' experience was seen in only 18% of 129 individuals with significant CNS findings [Author, unpublished observation]. Seizures are seen in some individuals and are most often, but not always, associated with hypocalcemia. In one study, 7% (27/383) of persons with 22q11.2DS had unprovoked seizures [<a class="bk_pop" href="#gr_22q11deletion.REF.kao.2004.29">Kao et al 2004</a>].</p><p>Several individuals have asymmetric crying facies [<a class="bk_pop" href="#gr_22q11deletion.REF.cayler.1969.69">Cayler 1969</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.levin.1982.227">Levin et al 1982</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.silengo.1986.481">Silengo et al 1986</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.sanklecha.1992.147">Sanklecha et al 1992</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.giannotti.1994.303">Giannotti et al 1994</a>], which may be an independent clue to the diagnosis.</p><p>Rarely, ataxia and atrophy of the cerebellum are observed [<a class="bk_pop" href="#gr_22q11deletion.REF.lynch.1995.561">Lynch et al 1995</a>].</p><p>Additional CNS abnormalities include multicystic white matter lesions of <a class="def" href="/books/n/gene/glossary/def-item/unknown-significance/">unknown significance</a> and perisylvian dysplasia [<a class="bk_pop" href="#gr_22q11deletion.REF.bingham.1997.538">Bingham et al 1997</a>], hypoplastic pituitary gland, and polymicrogyria (see <a href="/books/n/gene/poly/">Polymicrogyria Overview</a>).</p><p>Recent investigations utilizing functional MRI scans revealed significantly reduced posterior brain volumes relative to age- and sex-matched controls with more significant white matter loss in the left occipital and left parietal regions than in the frontal lobes [<a class="bk_pop" href="#gr_22q11deletion.REF.barneagoraly.2003.1863">Barnea-Goraly et al 2003</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.bearden.2004.198">Bearden et al 2004</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.bish.2004.1413">Bish et al 2004</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.kates.2004.337">Kates et al 2004</a>]. Many of these changes in brain structure can be postulated to relate to the specific cognitive deficits exhibited in the area of working memory, executive function, visuospatial skill, language, and math performance.</p><p>Overall, the pattern of CNS abnormalities is broad and overlaps with that seen in some cases of Opitz G/BBB syndrome [<a class="bk_pop" href="#gr_22q11deletion.REF.neri.1987.287">Neri et al 1987</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.guionalmeida.1992.918">Guion-Almeida &#x00026; Richieri-Costa 1992</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.macdonald.1993.706">MacDonald et al 1993</a>].</p><p><b>Psychosocial development and cognitive function.</b> In general, young children with 22q11.2DS have delays in motor milestones (walking at 18 months mean age), delay in emergence of language (many are nonverbal at age 2-3 years), and autism/autistic spectrum disorders in approximately 20% [<a class="bk_pop" href="#gr_22q11deletion.REF.fine.2005.461">Fine et al 2005</a>].</p><p>Specifically, in a study of 28 toddlers assessed with standardized tests, mental development was average in 21%, mildly delayed in 32%, and significantly delayed in 46%; in motor development, 8% were average, 13% were mildly delayed, and 79% were significantly delayed.</p><p>In a group of 12 preschoolers assessed using the WPPSI-R, the full scale IQ was 78&#x000b1;11, the mean performance IQ was 78&#x000b1;14, and the mean verbal IQ was 82&#x000b1;15. In total language, 16% were average, 44% were mildly delayed, and 40% were significantly delayed [<a class="bk_pop" href="#gr_22q11deletion.REF.solot.1998">Solot et al 1998</a>].</p><p>In a group of 80 school-aged children assessed with the age-appropriate Weschler IQ test, the mean IQ score was 76; 18% attained full scale IQ scores in the average range, 20% in the low-average range, 32% in the borderline range, and 30% in the intellectually disabled range.</p><p>Older individuals with 22q11.2DS generally have an atypical neuropsychologic profile across multiple domains, the most striking aspect of which is a significantly higher verbal IQ score than performance IQ score. <a class="bk_pop" href="#gr_22q11deletion.REF.moss.1995.a42">Moss et al [1995]</a> observed a mean split between the verbal IQ and performance IQ in 66% of 80 school-age children consistent with a nonverbal learning disability that is rare in the general population [<a class="bk_pop" href="#gr_22q11deletion.REF.wang.1998.342">Wang et al 1998</a>]. Because the full scale IQ score alone does not accurately represent the abilities of many individuals with 22q11.2DS, verbal and performance IQ scores need to be considered separately. In addition, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals exhibit relative strengths in the areas of rote verbal learning and memory, reading decoding, and spelling. Deficits are found in the areas of nonverbal processing, visual-spatial skills, complex verbal memory, attention, working memory, visual-spatial memory, and mathematics. This evidence of stronger verbal than visual memory skills and stronger reading than math skills also supports the presence of a nonverbal learning disorder that requires specific cognitive remediation, behavior management, and parental counseling.</p><p><b>Psychiatric illness.</b> Behavior and temperament observed in some individuals with 22q11.2DS include disinhibition and impulsiveness on the one hand and shyness and withdrawal on the other [<a class="bk_pop" href="#gr_22q11deletion.REF.swillen.1999.230">Swillen et al 1999</a>]. Attention deficit, anxiety, perseveration, and difficulty with social interactions are also common, along with autism and autistic spectrum disorders [<a class="bk_pop" href="#gr_22q11deletion.REF.swillen.1999.230">Swillen et al 1999</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.niklasson.2001.79">Niklasson et al 2001</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.vorstman.2006.1104">Vorstman et al 2006</a>]. The incidence of psychiatric disorders, including schizophrenia, bipolar disorder, anxiety, and depression, is increased. The prevalence and exact nature of these psychiatric disorders has been a subject of investigation [<a class="bk_pop" href="#gr_22q11deletion.REF.shprintzen.1992.141">Shprintzen et al 1992</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.chow.1994.107">Chow et al 1994</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.bassett.1998.328">Bassett et al 1998</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.yan.1998.41">Yan et al 1998</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.murphy.1999.940">Murphy et al 1999</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.baker.2005.115">Baker &#x00026; Skuse 2005</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.bassett.2005.307">Bassett et al 2005</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.oskarsd_ttir.2005a.177">Oskarsd&#x000f3;ttir et al 2005a</a>].</p><p>It has been suggested that 60% of adults have a psychiatric disorder. Most notably, schizophrenia is identified in approximately 25% of individuals, however, anxiety and depressive disorders are also quite common [<a class="bk_pop" href="#gr_22q11deletion.REF.bassett.2011.332">Bassett et al 2011</a>]. Behavioral differences may begin at a young age; screening children with 22q11.2DS for psychiatric issues before age ten years may provide an opportunity for early intervention [<a class="bk_pop" href="#gr_22q11deletion.REF.vorstman.2006.1104">Vorstman et al 2006</a>].</p><p><b>Growth.</b> Most adults with 22q11.2DS are of normal stature; however, in 95 children between age one and 15 years, 41% were below the fifth percentile in height. Of these, four were significantly below the fifth percentile; all had low concentrations of growth factors IGF1 and IGFBP3. Three had evidence of growth hormone deficiency; three had a small pituitary gland on MRI; and two responded to human growth hormone therapy [<a class="bk_pop" href="#gr_22q11deletion.REF.weinzimer.1998.929">Weinzimer et al 1998</a>]. More recently, growth charts specific to 22q11.2DS have been developed [<a class="bk_pop" href="#gr_22q11deletion.REF.habel.2012.2665">Habel et al 2012</a>].</p><p><b>Autoimmune disease.</b> Polyarticular juvenile rheumatoid arthritis (JRA) occurs in children with 22q11.2DS at a frequency 20 times that in the general population. The age of onset of JRA ranges from 17 months to five years. HLA types permissive for the development of JRA are observed [<a class="bk_pop" href="#gr_22q11deletion.REF.keenan.1997.488">Keenan et al 1997</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.sullivan.1997.430">Sullivan et al 1997</a>]. Other autoimmune disorders associated with 22q11.2DS include: <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> thrombocytopenia purpura (ITP), hyperthyroidism (Grave's disease), hypothyroidism, vitiligo, hemolytic anemia, autoimmune neutropenia, aplastic anemia, and celiac disease. ITP is seen 200 times more frequently in individuals with 22q11.2DS than in the general population [<a class="bk_pop" href="#gr_22q11deletion.REF.sullivan.1997.430">Sullivan et al 1997</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.jawad.2001.715">Jawad et al 2001</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.kawame.2001.892">Kawame et al 2001</a>].</p><p><b>Musculoskeletal system.</b> Of 108 individuals evaluated for skeletal abnormalities, 6% had upper-extremity anomalies, including pre- and postaxial polydactyly, and 15% had lower-extremity anomalies including postaxial polydactyly, clubfoot, overfolded toes, and syndactyly of toes 2 and 3 [<a class="bk_pop" href="#gr_22q11deletion.REF.ming.1997.210">Ming et al 1997</a>].</p><p>Of 63 individuals on whom chest films were examined, 19% had vertebral anomalies including butterfly vertebrae, hemivertebrae, and coronal clefts; 19% had rib anomalies, most commonly supernumerary or absent ribs. Hypoplastic scapulae were seen in 1.5% [<a class="bk_pop" href="#gr_22q11deletion.REF.ming.1997.210">Ming et al 1997</a>]. Significant cervical spine abnormalities observed in 50% of 79 persons studied prospectively included posterior fusion of vertebrae C2-C3 without block vertebrae in 21%, hypoplastic/anomalous C1 in 75%, <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> C2 in 59%, and posterior element fusion with block vertebrae of C2-C3 in 13% [<a class="bk_pop" href="#gr_22q11deletion.REF.ricchetti.2004.1751">Ricchetti et al 2004</a>]. In addition, 56% of persons with cervical spine anomalies had instability on flexion and extension radiographs; 33% had increased motion at more than one vertebral level; of these, four children had abnormalities including increased C2-C3 segmental motion with anterior and posterior narrowing of the spinal canal on further examination with cervical CT scan and/or MRI. Two of the four had surgical stabilization; one of the two required an emergency procedure following onset of symptoms of spinal cord compression. More recently, scoliosis has been identified in 15% of 1067 patients evaluated [D Colo, personal communication].</p><p><b>Kidneys.</b> A prospective evaluation using renal ultrasonography in 80 individuals with 22q11.2DS who had no prior history of uropathy revealed renal or other GU abnormalities in 31% [<a class="bk_pop" href="#gr_22q11deletion.REF.wu.2002.2564">Wu et al 2002</a>]. These included single kidney, echogenic kidney, multicystic dysplastic kidney/small kidneys, calculi, bladder wall thickening, horseshoe kidney, duplicated collecting system, renal tubular acidosis, hydronephrosis (5%), and enuresis. The high incidence of renal abnormalities is similar to that reported by <a class="bk_pop" href="#gr_22q11deletion.REF.devriendt.1996.349">Devriendt et al [1996]</a>. In addition, hypospadias, undescended testes [<a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.1995.103">McDonald-McGinn et al 1995</a>] and absent uterus have been observed [<a class="bk_pop" href="#gr_22q11deletion.REF.sundaram.2007.2016">Sundaram et al 2007</a>].</p><p>More recently, records on 859 individuals with 22q11.2DS were reviewed for renal anomalies, single umbilical artery, polyhydramnios, and genitourinary abnormalities. Of these, 677 individuals had genitourinary evaluations, of whom 45% had abnormalities present including: umbilical hernia, inguinal hernia, chordee, phimosis, undescended testes, and hypospadias. Renal data was available on 530 individuals, of whom 24.5% had anomalies, including hydronephrosis and unilateral renal agenesis [<a class="bk_pop" href="#gr_22q11deletion.REF.amliewolf.2012">Amlie-Wolf et al 2012</a>].</p><p><b>Other.</b> Other findings observed in individuals with 22q11.2DS include:</p><ul><li class="half_rhythm"><div>Abnormal lung lobation [<a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.1995.103">McDonald-McGinn et al 1995</a>]</div></li><li class="half_rhythm"><div>Bernard-Soulier syndrome (BSS) [<a class="bk_pop" href="#gr_22q11deletion.REF.budarf.1995.763">Budarf et al 1995</a>], an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder of thrombocytopenia and giant platelets caused by a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of four genes. One of the four genes is <i>GP1BB</i>, at <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> 22q11.2. BSS is associated with 22q11.2DS in persons whose non-deleted chromosome 22 has a pathogenic variant in <i>GP1BB</i>. Individuals with both 22q11.2DS and BSS are particularly susceptible to bleeding secondary to surgical procedures.</div></li><li class="half_rhythm"><div>Malignancies including hepatoblastoma [<a class="bk_pop" href="#gr_22q11deletion.REF.patrone.1990.425">Patrone et al 1990</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.scattone.2003.323">Scattone et al 2003</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.2006.906">McDonald-McGinn et al 2006</a>], renal cell carcinoma [<a class="bk_pop" href="#gr_22q11deletion.REF.scattone.2003.323">Scattone et al 2003</a>], Wilms tumor [<a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.2006.906">McDonald-McGinn et al 2006</a>], and neuroblastoma. Based on these reports a causal relationship between 22q11.2DS and hepatoblastoma seems likely as the population incidence of hepatoblastoma is 1:1,000,000. It is theorized that the absence of <i>COMT</i>, which is located within the area of the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, causes this increase in incidence of hepatoblastoma as <i>COMT</i> usually allows for the effective detoxification of environmental carcinogens, the early exposure to which is believed to cause such malignancies [<a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.2006.906">McDonald-McGinn et al 2006</a>].</div></li><li class="half_rhythm"><div>CEDNIK syndrome, an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder of cerebral dysgenesis (polymicrogyria), neuropathy, ichthyosis, and keratoderma caused by pathogenic variants in <i>SNAP29</i> (<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> 22q11.2). Two individuals with 22q11.2DS who had a 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on one 22q homolog and a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SNAP29</i> on the remaining 22q11.2 homolog were recently reported [<a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.2013.80">McDonald-McGinn et al 2013</a>].</div></li></ul></div><div id="gr_22q11deletion.GenotypePhenotype_Corre"><h3>Genotype-Phenotype Correlations</h3><p>The great inter- and intrafamilial clinical variability, even among identical twins, makes <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> difficult [<a class="bk_pop" href="#gr_22q11deletion.REF.driscoll.1995">Driscoll et al 1995</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.2001.23">McDonald-McGinn et al 2001</a>]. Anecdotally, developmental delays appear to be more significant in <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases; however, this may reflect socioeconomic rather than genetic factors.</p></div><div id="gr_22q11deletion.Penetrance"><h3>Penetrance</h3><p>Penetrance is complete in individuals with 22q112DS; variability is marked.</p></div><div id="gr_22q11deletion.Anticipation"><h3>Anticipation</h3><p>To date, <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a> has not been observed.</p></div><div id="gr_22q11deletion.Nomenclature"><h3>Nomenclature</h3><p>It is now recognized that 22q11.2DS encompasses the phenotypes previously described as DiGeorge syndrome (DGS) [<a class="bk_pop" href="#gr_22q11deletion.REF.kelley.1982.197">Kelley et al 1982</a>], velocardiofacial syndrome (VCFS) [<a class="bk_pop" href="#gr_22q11deletion.REF.scambler.1991.201">Scambler et al 1991</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.driscoll.1992.924">Driscoll et al 1992</a>], conotruncal anomaly face syndrome (CTAF) [<a class="bk_pop" href="#gr_22q11deletion.REF.matsuoka.1994.285">Matsuoka et al 1994</a>], some cases of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> Opitz G/BBB syndrome [<a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.1995.103">McDonald-McGinn et al 1995</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.fryburg.1996.274">Fryburg et al 1996</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.lacassie.1996.318">Lacassie &#x00026; Arriaza 1996</a>], and Cayler cardiofacial syndrome (asymmetric crying facies) [<a class="bk_pop" href="#gr_22q11deletion.REF.giannotti.1994.303">Giannotti et al 1994</a>]. The clinical descriptions of these entities resulted from an ascertainment bias.</p><p>DGS was originally described as a developmental field defect of the third and fourth pharyngeal pouches, often identified in neonates, with hypoplasia of the thymus gland and parathyroid glands. Later, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease, specifically conotruncal cardiac anomalies, was added. The majority of individuals with DGS were identified in the neonatal period with a major congenital heart defect, hypocalcemia, and immunodeficiency.</p><p>VCFS, was originally described as the combination of palatal anomalies, often velopharyngeal incompetence (VPI), <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease (usually a ventricular septal defect or tetralogy of Fallot), characteristic facial features, and developmental delay or learning difficulties. Children with VCFS tended to be diagnosed in cleft palate clinics or craniofacial centers when they reached school age and speech and learning difficulties became evident [<a class="bk_pop" href="#gr_22q11deletion.REF.driscoll.1993.813">Driscoll et al 1993</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.wilson.1993.852">Wilson et al 1993</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.wulfsberg.1996.317">Wulfsberg et al 1996</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.1997b.247">McDonald-McGinn et al 1997b</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.thomas.1997.253">Thomas &#x00026; Graham 1997</a>]. VCFS may be referred to as Shprintzen syndrome.</p><p>Autosomal dominant Opitz G/BBB syndrome may also be referred to as hypertelorism with esophageal abnormality and hypospadias.</p></div><div id="gr_22q11deletion.Prevalence"><h3>Prevalence</h3><p>Estimates of prevalence vary from one in 4000 [<a class="bk_pop" href="#gr_22q11deletion.REF.wilson.1994.a169">Wilson et al 1994</a>] to one in 6395 [<a class="bk_pop" href="#gr_22q11deletion.REF.devriendt.1998.789">Devriendt et al 1998</a>]. Given the variable expression of 22q11.2DS, the incidence is probably much higher than previously estimated. In a population-based study in Sweden, the mean annual incidence was 14.1 per 100,000 live births [<a class="bk_pop" href="#gr_22q11deletion.REF.oskarsd_ttir.2004.148">Oskarsd&#x000f3;ttir et al 2004</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.oskarsd_ttir.2005a.177">Oskarsd&#x000f3;ttir et al 2005a</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.oskarsd_ttir.2005b.146">Oskarsd&#x000f3;ttir et al 2005b</a>]. A US population-based study conducted by the Centers for Disease Control (CDC) found an overall prevalence of about one in 6000 in whites, blacks, and Asians, and one in 3800 in Hispanics [<a class="bk_pop" href="#gr_22q11deletion.REF.botto.2003.101">Botto et al 2003</a>].</p><p>In a recent review of samples submitted to two large reference labs for numerous indications, such as developmental delay or multiple spontaneous abortions, 30,153 individuals underwent array CGH testing. Of these, 274 were found to have a 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> (~1/100) [<a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.a">McDonald-McGinn et al 2010a</a>] suggesting that, despite bias based on ascertainment, the current prevalence figures may be underestimates. Moreover, <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> efforts currently underway in several states will serve to better define these figures over time.</p><p>The widespread use of <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> technology to detect smaller atypical, "nested" deletions has suggested that the prevalence of 22q11.2DS is even higher than previous estimates. One review evaluated a cohort of 904 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, of whom 436 had <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> sizing by enhanced <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> or microarray studies. Of these, 63 (15%) had atypical deletions, including 28 A-B (44%), 10 A-C (16%), 17 B-D (27%), 2 C-D (3%), &#x00026; 6 "other" (10%) (not flanked by LCR blocks) (see <a class="figpopup" href="/books/NBK1523/figure/gr_22q11deletion.F2/?report=objectonly" target="object" rid-figpopup="figgr22q11deletionF2" rid-ob="figobgr22q11deletionF2">Figure 2</a>). The B-D and the less common C-D deletions do not include <i>TBX1</i> and are not detectable using standard FISH probes. A high incidence of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> deletions was noted among the individuals with these atypical deletions. Many adults therefore go undiagnosed until the deletion is detected in a more dramatically affected child [<a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.a">McDonald-McGinn et al 2010a</a>].</p></div></div><div id="gr_22q11deletion.Genetically_Related_Dis"><h2 id="_gr_22q11deletion_Genetically_Related_Dis_">Genetically Related Disorders</h2><p>The 22q11.2DS is associated with the phenotypes described in this <i>GeneReview</i>. No other phenotypes are associated with <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 22q11.2. See <a href="#gr_22q11deletion.Nomenclature">Nomenclature</a> for a discussion of previous clinically defined syndromes that have now all been found to be due to the 22q11.2DS.</p></div><div id="gr_22q11deletion.Differential_Diagnosis"><h2 id="_gr_22q11deletion_Differential_Diagnosis_">Differential Diagnosis</h2><p>All of the findings appreciated in association with 22q11.2DS can also be found as an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> anomaly in an otherwise normal individual.</p><p>Up to11% of individuals with an apparently <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> cleft palate, including submucosal cleft, may have 22q11.2DS, making this the most common genetic syndrome associated with palatal clefts. 22q11.2DS is also the most common genetic cause of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> velopharyngeal incompetence.</p><p><b><i>TBX1.</i></b> Pathogenic variants in <i>TBX1,</i> a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> located within the A-B region of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22q11.2, have been found in individuals with clinical features of 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a>, primarily <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cardiac anomalies, who do not have a deletion [<a class="bk_pop" href="#gr_22q11deletion.REF.gong.2001.e45">Gong et al 2001</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.yagi.2003.1366">Yagi et al 2003</a>]; at least one of these pathogenic variants affects function [<a class="bk_pop" href="#gr_22q11deletion.REF.stoller.2005.885">Stoller &#x00026; Epstein 2005</a>]. It is still uncertain what other genes must be deleted, since pathogenic variants in <i>TBX1</i> do not account for all of the features of deletion 22q11.2 syndrome. Moreover, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with atypical nested deletions which do not include <i>TBX1</i> (B-D deletions; <a class="figpopup" href="/books/NBK1523/figure/gr_22q11deletion.F2/?report=objectonly" target="object" rid-figpopup="figgr22q11deletionF2" rid-ob="figobgr22q11deletionF2">Figure 2</a>) have now been reported, including individuals with typical conotruncal cardiac defects such TOF, IAA, and truncus arteriosus, thus suggesting either a downstream effect or the involvement of <i>CRKL</i> (see <a class="figpopup" href="/books/NBK1523/figure/gr_22q11deletion.F2/?report=objectonly" target="object" rid-figpopup="figgr22q11deletionF2" rid-ob="figobgr22q11deletionF2">Figure 2</a>) [<a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.a">McDonald-McGinn et al 2010a</a>].</p><p>Furthermore, some individuals with features of the 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a>, including typical conotruncal cardiac anomalies, have neither an identifiable deletion nor a <i>TBX1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. However, many of these individuals were subsequently found to have CHARGE syndrome, caused by pathogenic variants in <i>CHD7</i> [<a class="bk_pop" href="#gr_22q11deletion.REF.jyonouchi.2009.e871">Jyonouchi et al 2009</a>].</p><p>Disorders with overlapping features:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/slo/">Smith-Lemli-Opitz syndrome</a> (when polydactyly and cleft palate are present). Smith-Lemli-Opitz syndrome, an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inborn error of metabolism is associated with elevated serum concentration of 7-dehydrocholesterol (7-DHC) or an elevated 7-dehydrocholesterol:cholesterol ratio. Pathogenic variants in <i>DHCR7</i> are causative.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/alagille/">Alagille syndrome</a> (when butterfly vertebrae, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease, and posterior embryotoxon are present). Alagille syndrome is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition where <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the <i>JAG1</i> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> detects pathogenic variants in approximately 88% of individuals who meet clinical diagnostic criteria. <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> detects a microdeletion of 20p12, including the entire <i>JAG1</i> gene, in approximately 7% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Pathogenic variants in <i>NOTCH2</i> are observed in fewer than 1% of individuals with Alagille syndrome.</div></li><li class="half_rhythm"><div>VATER association (when heart disease, vertebral, renal, and limb anomalies are present). VATER association is a diagnosis of exclusion without an established etiology to date.</div></li><li class="half_rhythm"><div>Oculo-auriculo vertebral (Goldenhar) syndrome (OAVS) (when ear anomalies, vertebral defects, heart disease, renal anomalies are present). OAVS is often a <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> condition.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/charge/">CHARGE syndrome</a> (when any combination of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease, palatal differences, coloboma, atresia choanae, renal, growth deficiency, ear anomalies/hearing loss, developmental differences, facial palsy GU anomalies,and immunodeficiency are present). Pathogenic variants in <i>CHD7</i> are found in about 65%-70% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. CHARGE syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> fashion, although most affected individuals represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family).</div></li></ul><p>Individuals with normal <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> studies suspected of having 22q11.2DS may have (a) an atypical nested 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> which would not include the A-B region of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 22q11.2 or (b) a chromosome abnormality involving some other chromosome region including deletion 10p13-p14 (although (b) is believed to be a distinct entity).</p></div><div id="gr_22q11deletion.Management"><h2 id="_gr_22q11deletion_Management_">Management</h2><div id="gr_22q11deletion.Evaluations_Following_I"><h3>Evaluations Following Initial Diagnosis</h3><p>Clinical practice guidelines for the evaluation and treatment of individuals with 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a> have been published [<a class="bk_pop" href="#gr_22q11deletion.REF.bassett.2011.332">Bassett et al 2011</a>] (<a href="/pmc/articles/PMC3197829/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>).</p><p>To establish the extent of disease and the needs of an individual diagnosed with 22q11.2DS, the following evaluations are recommended (if not performed as part of the evaluation that led to the diagnosis):</p><ul><li class="half_rhythm"><div>A baseline cardiac evaluation by a cardiologist that includes a chest x-ray, ECG, and echocardiogram; a chest MRI may be required if a vascular ring is suspected.</div></li><li class="half_rhythm"><div>Measurement of serum ionized calcium concentration and intact parathyroid hormone level to assess for hypoparathyroidism, followed by a formal endocrinology evaluation if abnormal</div></li><li class="half_rhythm"><div>TSH level</div></li><li class="half_rhythm"><div>Complete blood cell count with differential. A low absolute lymphocyte count necessitates evaluation of T- and B-cell subsets and referral to an immunologist.</div></li><li class="half_rhythm"><div>Immunologic evaluation, which may include flow cytometry, immunoglobulins, and T-cell function</div></li><li class="half_rhythm"><div>Renal ultrasound examination to evaluate for structural renal defects</div></li><li class="half_rhythm"><div>Consideration of ophthalmology evaluation</div></li><li class="half_rhythm"><div>Audiology evaluation</div></li><li class="half_rhythm"><div>Chest x-ray to evaluate for thoracic vertebral anomalies</div></li><li class="half_rhythm"><div>Cervical spine films (six views: flexion, extension, AP, lateral, open mouth, skull base) in all individuals over age four years (the age that the cervical spine becomes better ossified)</div></li><li class="half_rhythm"><div>Clinical evaluation of the palate to screen for palatal anomalies which may affect feeding and speech development</div></li><li class="half_rhythm"><div>Assessment for possible feeding problems including significant gastroesophageal reflux; difficulty with sucking/swallowing, advancing feeds, addition of textured foods; vomiting and constipation</div></li><li class="half_rhythm"><div>Speech and language assessment by age one year given that almost all children with 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a> have delay in emergence of language and would benefit from early intervention strategies. In addition, such an evaluation aids in the diagnosis of a palatal abnormality/VPI.</div></li></ul><p>As needed:</p><ul><li class="half_rhythm"><div>Evaluation of children with short stature (height below the 2nd percentile) by an endocrinologist for possible growth hormone deficiency</div></li><li class="half_rhythm"><div>Evaluation by a psychologist or psychiatrist of any person with evidence of anxiety, mood disorder, behavioral differences, or frank psychosis</div></li><li class="half_rhythm"><div>Evaluation by a hematologist of any person with a history of a bruising/bleeding disorder</div></li></ul></div><div id="gr_22q11deletion.Treatment_of_Manifestat"><h3>Treatment of Manifestations</h3><p>Depending on the age and presenting problems of the individual with the 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a>, a multidisciplinary evaluation involving health care providers from the following specialties is often necessary: allergy, audiology, cardiology, cardiac surgery, child development / psychology, dental, endocrine, ENT, feeding, gastroenterology, general pediatrics, general surgery, immunology, clinical genetics, neurology, neurosurgery, ophthalmology, orthopedics, otolaryngology, plastic surgery, psychiatry, pulmonary, rheumatology, speech, and urology.</p><p>Low serum calcium concentration warrants calcium supplementation in a standard manner and, when possible, referral to an endocrinologist/nephrologist because of the increased risk of renal calculi in individuals on long-term calcium supplementation.</p><p>Feeding difficulties should be evaluated by a gastroenterologist to assess for possible structural abnormalities such as intestinal malrotation/nonrotation, Hirschsprung disease, and late-onset diaphragmatic hernia [<a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.2004">McDonald-McGinn et al 2004</a>].</p><p>Strategies for addressing feeding difficulties include: modification of spoon placement when eating; treatment for gastroesophageal reflux with acid blockade, prokinetic agents, postural therapy; and medication to treat gastrointestinal dysmotility and to facilitate bowel evacuation [<a class="bk_pop" href="#gr_22q11deletion.REF.dinulos.1998">Dinulos &#x00026; Graf 1998</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.eicher.2000.158">Eicher et al 2000</a>].</p><p>Early intervention (occupational therapy, physical therapy) and speech therapy/the introduction of sign language should be instituted by age one year or at presentation in childhood because of the high risk for motor, cognitive, speech, and language delay. Later, educational and behavioral therapy are often warranted.</p><p>Growth hormone deficiency, if present, should be treated as in the general population.</p><p>Immune deficiency generally requires no specific intervention except treating infections aggressively. Rarely, prophylactic antibiotics, IVIG therapy, or thymic transplantation are required.</p><p>Early diagnosis and early intervention for psychiatric illnesses improve long-term prognosis in individuals with schizophrenia and bipolar disorder [<a class="bk_pop" href="#gr_22q11deletion.REF.clarke.2003.65">Clarke &#x00026; O'Callaghan 2003</a>] and other disorders including autism, anxiety, obsessive compulsive disorder (OCD), and attention deficit hyperactivity disorder/attention deficit disorder (ADHD/ADD) [<a class="bk_pop" href="#gr_22q11deletion.REF.vorstman.2006.1104">Vorstman et al 2006</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.bassett.2011.332">Bassett et al 2011</a>].</p></div><div id="gr_22q11deletion.Prevention_of_Secondary"><h3>Prevention of Secondary Complications</h3><p>Infants with lymphocyte abnormalities should not be immunized with live vaccines (i.e., oral polio, MMR). Their immune status should be reevaluated in childhood before receiving live vaccines.</p><p>Antibody studies to assess results of immunizations are warranted.</p><p>Irradiated blood products are recommended until normalization of the immune system can be confirmed.</p><p>Serum ionized calcium concentration should be measured pre- and postoperatively to avoid hypocalcemic seizures due to physical stress.</p><p>Consider the following:</p><ul><li class="half_rhythm"><div>Assessment of carotid arteries prior to surgical procedures involving the pharynx</div></li><li class="half_rhythm"><div>Possible effects on speech prior to adenoidectomy</div></li><li class="half_rhythm"><div>Assessment of cervical spine anomalies prior to hyperextension of the neck during surgical procedures/athletic pursuits, such as tumbling</div></li><li class="half_rhythm"><div>Pre- and postoperative sleep studies when performing pharyngeal procedures</div></li><li class="half_rhythm"><div>Assessment of platelet volume and function prior to surgical procedures</div></li></ul></div><div id="gr_22q11deletion.Surveillance"><h3>Surveillance</h3><p>Affected individuals require follow up as needed on a "system by system" basis:</p><ul><li class="half_rhythm"><div>Monitoring for hypocalcemia, including ionized calcium level every three to six months in infancy, every five years through childhood, and every one to two years thereafter</div></li><li class="half_rhythm"><div>Monitoring of calcium levels preoperatively and postoperatively, and regularly during pregnancy</div></li><li class="half_rhythm"><div>Thyroid studies annually</div></li><li class="half_rhythm"><div>Reevaluation of immunologic status between age nine and 12 months; consideration of repeat immunologic evaluation prior to any live virus vaccine</div></li><li class="half_rhythm"><div>Annual complete blood count and differential</div></li><li class="half_rhythm"><div>Repeat ophthalmologic evaluation between age one and five years, or as needed based on symptoms</div></li><li class="half_rhythm"><div>Evaluation of nasal speech quality after language emersion to screen for VPI</div></li><li class="half_rhythm"><div>Repeat audiology evaluation in infancy and prior to school enrollment</div></li><li class="half_rhythm"><div>Routine surveillance for the development of scoliosis</div></li><li class="half_rhythm"><div>Routine dental care with consideration of sealants in those individuals with enamel hypoplasia/increased incidence of caries</div></li><li class="half_rhythm"><div>Regular developmental assessments benefit the child and assist the school in providing appropriate remediation.</div></li></ul><p>Periodic reevaluation by a clinical geneticist can apprise the family of new developments and/or recommendations.</p></div><div id="gr_22q11deletion.AgentsCircumstances_to"><h3>Agents/Circumstances to Avoid</h3><p>Carbonated drinks and alcohol consumption may exacerbate hypocalcemia. Caffeine intake may contribute to or worsen anxiety.</p></div><div id="gr_22q11deletion.Evaluation_of_Relatives"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#gr_22q11deletion.Related_Genetic_Counsel">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="gr_22q11deletion.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Pregnant women must be monitored medically, taking into account any preexisting conditions including <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease, scoliosis, and asthma. Additional surveillance should include calcium, thyroid, and platelet levels. In addition, changes in mental status/behavior should be referred for immediate evaluation by a mental health care provider.</p><p>A fetus at high risk of having the condition should undergo a level II ultrasound with fetal echocardiogram to evaluate for the following anomalies : <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease; airway, palate, swallowing, and gastrointestinal differences possibly leading to polyhydramnios (congenital diaphragmatic hernia, tracheoesophageal fistula, subglottic stenosis, vascular ring, laryngeal web, and cleft palate/cleft lip/palate); renal anomalies; skeletal differences such as clubfoot and craniosynostosis; and umbilical and inguinal hernia.</p></div><div id="gr_22q11deletion.Therapies_Under_Investi"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="gr_22q11deletion.Genetic_Counseling"><h2 id="_gr_22q11deletion_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="gr_22q11deletion.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a> (DS) is a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion-syndrome/">contiguous gene deletion syndrome</a> inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="gr_22q11deletion.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>More than 90% of probands have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 22q11.2 [<a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.2001.23">McDonald-McGinn et al 2001</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.bassett.2011.332">Bassett et al 2011</a>].</div></li><li class="half_rhythm"><div>About 10% have inherited the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> from a parent [<a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.2001.23">McDonald-McGinn et al 2001</a>].</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> include either <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> or MLPA testing, as mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> adults (as well as normal adults with <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a>) have been identified [<a class="bk_pop" href="#gr_22q11deletion.REF.mcdonaldmcginn.2001.23">McDonald-McGinn et al 2001</a>].</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of a proband depends on the status of the parents:</p><ul><li class="half_rhythm"><div>If the parents of an individual with 22q11.2DS have normal studies, the risk to sibs is low, but greater than that of the general population because parents with <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> or low-level <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> have been identified.</div></li><li class="half_rhythm"><div>If a parent also has 22q11.2DS, the risk to each sib is 50%.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Offspring of individuals with 22q11.2DS have a 50% chance of inheriting 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the status of the proband's parents: if a parent has the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, his or her family members are at risk.</p></div><div id="gr_22q11deletion.Related_Genetic_Counsel"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</p></div><div id="gr_22q11deletion.Prenatal_Testing"><h3>Prenatal Testing</h3><p><b>High-risk pregnancies</b></p><ul><li class="half_rhythm"><div><b>Molecular genetic testing.</b> Prenatal testing using <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>, MLPA, or array studies is possible based on family history or findings on ultrasound. Fetal cells obtained by amniocentesis usually performed at about 15 to 18 weeks' gestation or CVS at approximately ten to 12 weeks' gestation can be analyzed.</div></li><li class="half_rhythm"><div><b>Ultrasound evaluation.</b> Pregnancies at increased risk may be evaluated between 18 and 22 weeks' gestation by high-resolution ultrasound examination for palatal and other associated anomalies and by echocardiography for cardiac anomalies.</div></li></ul><p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p><p><b>Low-risk pregnancies.</b> In some pregnancies not known by family history to be at increased risk for 22q11.2DS, findings of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease and/or cleft palate or cleft lip/palate detected by routine ultrasound examination may suggest the diagnosis, in particular in those individuals with conotruncal cardiac anomalies such as interrupted aortic arch, truncus arteriosus, tetralogy of Fallot, and ventricular septal defect. Additional structural differences which can be associated with 22q11.2DS and may be identified prenatally include: congenital diaphragmatic hernia, umbilical or inguinal hernia, tracheoesophageal fistula/esophageal atresia/laryngeal atresia, polydactyly, craniosynostosis, polymicrogyria, and renal anomalies. In addition, polyhydramnios is frequently present. Chromosome preparations obtained from fetal cells can be analyzed using array studies, MLPA, or <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>. Establishing the diagnosis of 22q11.2DS even late in gestation can be useful for perinatal management.</p><p><b>Preimplantation genetic diagnosis</b> may be an option for some families in which the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified.</p></div></div><div id="gr_22q11deletion.Resources"><h2 id="_gr_22q11deletion_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>International 22q11.2 Deletion Syndrome Foundation, Inc.</b></div><div>P.O. Box 2269</div><div>Cinnaminson NJ 08077</div><div><b>Phone:</b> 877-739-1849 (toll-free)</div><div><b>Email:</b> info@22q.org</div><div><a href="http://www.22q.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.22q.org</a></div></li><li class="half_rhythm"><div><b>Max Appeal</b></div><div>15 Meridian Avenue</div><div>Stourbridge West Midlands DY8 1049</div><div>United Kingdom</div><div><b>Phone:</b> 0800 389 1049 toll free</div><div><b>Email:</b> info@maxappeal.org.uk</div><div><a href="http://www.maxappeal.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.maxappeal.org.uk</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=22q11.2%20deletion%20syndrome&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">22q11.2 deletion syndrome</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=22q112deletionsyndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">22q11.2 deletion syndrome</a></div></li><li class="half_rhythm"><div><b>NCBI Genes and Disease</b></div><div><a href="/books/NBK22179/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DiGeorge syndrome</a></div></li><li class="half_rhythm"><div><b>Chromosome 22 Central</b></div><div>c/o Murney Rinholm</div><div>7108 Partinwood Drive</div><div>Fuquay-Varina NC 27526</div><div><b>Phone:</b> 919-567-8167</div><div><b>Email:</b> usinfo@c22c.org</div><div><a href="http://www.c22c.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.c22c.org</a></div></li><li class="half_rhythm"><div><b>Chromosome Disorder Outreach (CDO)</b></div><div>PO Box 724</div><div>Boca Raton FL 33429-0724</div><div><b>Phone:</b> 561-395-4252 (Family Helpline)</div><div><b>Email:</b> info@chromodisorder.org</div><div><a href="http://www.chromodisorder.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.chromodisorder.org</a></div></li><li class="half_rhythm"><div><b>Medical Home Portal</b></div><div><i>The Parents &#x00026; Families section of the Medical Home Portal provides information and resources to help families learn how to better care for a child with chronic and complex conditions and to become more effective partners in their child&#x02019;s care.</i></div><div>Department of Pediatrics University of Utah</div><div>P.O. Box 581289</div><div>Salt Lake City UT 84158</div><div><b>Phone:</b> 801-213-3920</div><div><b>Email:</b> info@medicalhomeportal.org</div><div><a href="https://www.medicalhomeportal.org/living-with-child" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">For Parents &#x00026; Families</a></div></li><li class="half_rhythm"><div><b>European Society for Immunodeficiencies (ESID) Registry</b></div><div>Dr. Gerhard Kindle</div><div>University Medical Center Freiburg Centre of Chronic Immunodeficiency</div><div>Engesserstr. 4</div><div>79106 Freiburg </div><div>Germany</div><div><b>Phone:</b> 49-761-270-34450</div><div><b>Email:</b> esid-registry@uniklinik-freiburg.de</div><div><a href="http://esid.org/Working-Parties/Registry" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ESID Registry</a></div></li></ul></div><div id="gr_22q11deletion.Molecular_Genetics"><h2 id="_gr_22q11deletion_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="gr_22q11deletion.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>22q11.2 Deletion Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1523/table/gr_22q11deletion.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gr_22q11deletion.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_gr_22q11deletion.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Critical Region</th><th id="hd_b_gr_22q11deletion.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_gr_22q11deletion.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_gr_22q11deletion.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_gr_22q11deletion.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_gr_22q11deletion.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_gr_22q11deletion.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_gr_22q11deletion.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">DGCR</td><td headers="hd_b_gr_22q11deletion.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><i>Not applicable</i></td><td headers="hd_b_gr_22q11deletion.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">22q11.2</td><td headers="hd_b_gr_22q11deletion.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Not applicable</td><td headers="hd_b_gr_22q11deletion.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_gr_22q11deletion.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_gr_22q11deletion.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_b_gr_22q11deletion.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_gr_22q11deletion.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6899" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TBX1</i></a></td><td headers="hd_b_gr_22q11deletion.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6899" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">22q11<wbr style="display:inline-block"></wbr>​.21</a></td><td headers="hd_b_gr_22q11deletion.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O43435" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">T-box transcription factor TBX1</a></td><td headers="hd_b_gr_22q11deletion.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/TBX1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TBX1 database</a></td><td headers="hd_b_gr_22q11deletion.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TBX1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TBX1</a></td><td headers="hd_b_gr_22q11deletion.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TBX1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TBX1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="gr_22q11deletion.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="gr_22q11deletion.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for 22q11.2 Deletion Syndrome (<a href="/omim/145410,188400,192430,600594,601279,601755,602054,609030" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1523/table/gr_22q11deletion.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gr_22q11deletion.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/145410" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">145410</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">OPITZ GBBB SYNDROME, TYPE II; GBBB2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/188400" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">188400</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DIGEORGE SYNDROME; DGS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/192430" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">192430</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">VELOCARDIOFACIAL SYNDROME</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600594" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600594</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DIGEORGE SYNDROME CRITICAL REGION GENE 2; DGCR2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601279" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601279</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DIGEORGE SYNDROME CRITICAL REGION GENE 6; DGCR6</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601755" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601755</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ESS2 SPLICING FACTOR, XENOPUS, HOMOLOG OF; ESS2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602054" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602054</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">T-BOX 1; TBX1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/609030" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">609030</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DIGEORGE SYNDROME CRITICAL REGION GENE 8; DGCR8</td></tr></tbody></table></div></div><p><b>DiGeorge <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> region.</b> A number of genes have been mapped within the DGCR on 22q11.2 (see <a href="/books/NBK1523/bin/gr_22q11deletion-Table4.pdf">Table 4</a> [pdf]).</p><p><b>Deletions.</b> More than 85% of individuals with a 22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> have deletions in the same approximately 2.54-Mb region; the remainder have either variant deletion endpoints or recurrent, atypical shorter deleted segments nested within the large typically deleted region (TDR) (see <a class="figpopup" href="/books/NBK1523/figure/gr_22q11deletion.F2/?report=objectonly" target="object" rid-figpopup="figgr22q11deletionF2" rid-ob="figobgr22q11deletionF2">Figure 2</a>) [<a class="bk_pop" href="#gr_22q11deletion.REF.levy.1995.2417">Levy et al 1995</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.kurahashi.1996.1377">Kurahashi et al 1996</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.odonnell.1997.1544">O'Donnell et al 1997</a>, <a class="bk_pop" href="#gr_22q11deletion.REF.mcquade.1999.27">McQuade et al 1999</a>]. A small 20-kb deletion within the TDR was reported in an individual with a classic VCFS/DGS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#gr_22q11deletion.REF.yamagishi.1999.1158">Yamagishi et al 1999</a>]. This smaller deletion disrupts <i>UFD1L</i> and <i>CDC45L</i>. In several additional <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, the deletions do not overlap the typically deleted region in that they begin distal to it and extend toward the telomere. The location of duplicated sequence blocks in the vicinity of the 22q11.2 deletion endpoints strongly implicates them in the events leading to the typical and atypical deletions.</p><p>A small number of individuals have the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> as the result of unbalanced translocations that delete the 22pter &#x02192;q11 region. (For more information, see <a href="/books/NBK1523/#gr_22q11deletion.molgen.TA">Table A</a>, <b>Locus Specific</b>)</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Several of the gene products from within the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> have been identified and are being further characterized. See <a href="/books/NBK1523/bin/gr_22q11deletion-Table4.pdf">Table 4</a> for a list of genes and their relevant gene products.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Unknown</p></div><div id="gr_22q11deletion.References"><h2 id="_gr_22q11deletion_References_">References</h2><div id="gr_22q11deletion.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.amliewolf.2012">Amlie-Wolf L, McDonald-McGinn DM, Valverde K, Devoto M, Mennuti M, Dickinson K, Bailey A, Lande R, Emanuel BS, Zackai EH. Renal anomalies, polyhydramnios, and single umbilical artery as prenatal clues to the diagnosis of 22q11.2 deletion syndrome. Lake Buena Vista, FL: Eighth Biennial International 22q11.2DS Conference. 2012.</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.baker.2005.115">Baker KD, Skuse DH. Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group. <span><span class="ref-journal">Br J Psychiatry. </span>2005;<span class="ref-vol">186</span>:115–20.</span> [<a href="/pubmed/15684233" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15684233</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.barneagoraly.2003.1863">Barnea-Goraly N, Menon V, Krasnow B, Ko A, Reiss A, Eliez S. Investigation of white matter structure in velocardiofacial syndrome: a diffusion tensor imaging study. <span><span class="ref-journal">Am J Psychiatry. </span>2003;<span class="ref-vol">160</span>:1863–9.</span> [<a href="/pubmed/14514502" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14514502</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.bassett.2005.307">Bassett AS, Chow EW, Husted J, Weksberg R, Caluseriu O, Webb GD, Gatzoulis MA. Clinical features of 78 adults with 22q11 deletion syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">138</span>:307–13.</span> [<a href="/pmc/articles/PMC3127862/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3127862</span></a>] [<a href="/pubmed/16208694" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16208694</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.bassett.1998.328">Bassett AS, Hodgkinson K, Chow EW, Correia S, Scutt LE, Weksberg R. 22q11 deletion syndrome in adults with schizophrenia. <span><span class="ref-journal">Am J Med Genet. </span>1998;<span class="ref-vol">81</span>:328–37.</span> [<a href="/pmc/articles/PMC3173497/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3173497</span></a>] [<a href="/pubmed/9674980" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9674980</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.bassett.2011.332">Bassett AS, McDonald-McGinn DM, Devriendt K, Digilio MC, Goldenberg P, Habel A, Marino B, Oskarsdottir S, Philip N, Sullivan K, Swillen A, Vorstman J. International 22q11.2 Deletion Syndrome Consortium. Practical guidelines for managing patients with 22q11.2 deletion syndrome. <span><span class="ref-journal">J Pediatr. </span>2011;<span class="ref-vol">159</span>:332–9.e1.</span> [<a href="/pmc/articles/PMC3197829/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3197829</span></a>] [<a href="/pubmed/21570089" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21570089</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.bearden.2004.198">Bearden CE, van Erp TG, Monterosso JR, Simon TJ, Glahn DC, Saleh PA, Hill NM, McDonald-McGinn DM, Zackai E, Emanuel BS, Cannon TD. Regional brain abnormalities in 22q11.2 deletion syndrome: association with cognitive abilities and behavioral symptoms. <span><span class="ref-journal">Neurocase. </span>2004;<span class="ref-vol">10</span>:198–206.</span> [<a href="/pubmed/15788257" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15788257</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.bingham.1997.538">Bingham PM, Zimmerman RA, McDonald-McGinn D, Driscoll D, Emanuel BS, Zackai E. Enlarged Sylvian fissures in infants with interstitial deletion of chromosome 22q11. <span><span class="ref-journal">Am J Med Genet. </span>1997;<span class="ref-vol">74</span>:538–43.</span> [<a href="/pubmed/9342208" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9342208</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.bish.2004.1413">Bish JP, Nguyen V, Ding L, Ferrante S, Simon TJ. Thalamic reductions in children with chromosome 22q11.2 deletion syndrome. <span><span class="ref-journal">Neuroreport. </span>2004;<span class="ref-vol">15</span>:1413–5.</span> [<a href="/pubmed/15194864" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15194864</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.botto.2003.101">Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, Merritt RK, O'Leary LA, Wong LY, Elixson EM, Mahle WT, Campbell RM. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. <span><span class="ref-journal">Pediatrics. </span>2003;<span class="ref-vol">112</span>:101–7.</span> [<a href="/pubmed/12837874" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12837874</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.budarf.1995.763">Budarf ML, Konkle BA, Ludlow LB, Michaud D, Li M, Yamashiro DJ, McDonald-McGinn D, Zackai EH, Driscoll DA. Identification of a patient with Bernard-Soulier syndrome and a deletion in the DiGeorge/velo-cardio-facial chromosomal region in 22q11.2. <span><span class="ref-journal">Hum Mol Genet. </span>1995;<span class="ref-vol">4</span>:763–6.</span> [<a href="/pubmed/7633430" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7633430</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.cayler.1969.69">Cayler GG. Cardiofacial syndrome. Congenital heart disease and facial weakness, a hitherto unrecognized association. <span><span class="ref-journal">Arch Dis Child. </span>1969;<span class="ref-vol">44</span>:69–75.</span> [<a href="/pmc/articles/PMC2020193/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2020193</span></a>] [<a href="/pubmed/5765991" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5765991</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.chow.1994.107">Chow EW, Bassett AS, Weksberg R. Velo-cardio-facial syndrome and psychotic disorders: implications for psychiatric genetics. <span><span class="ref-journal">Am J Med Genet. </span>1994;<span class="ref-vol">54</span>:107–12.</span> [<a href="/pmc/articles/PMC3142271/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3142271</span></a>] [<a href="/pubmed/8074160" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8074160</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.clarke.2003.65">Clarke M, O'Callaghan E. Is earlier better? At the beginning of schizophrenia: timing and opportunities for early intervention. <span><span class="ref-journal">Psychiatr Clin North Am. </span>2003;<span class="ref-vol">26</span>:65–83.</span> [<a href="/pubmed/12683260" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12683260</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.desmaze.1993.663">Desmaze C, Scambler P, Prieur M, Halford S, Sidi D, Le Deist F, Aurias A. Routine diagnosis of DiGeorge syndrome by fluorescent in situ hybridization. <span><span class="ref-journal">Hum Genet. </span>1993;<span class="ref-vol">90</span>:663–5.</span> [<a href="/pubmed/8444474" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8444474</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.devriendt.1998.789">Devriendt K, Fryns JP, Mortier G, van Thienen MN, Keymolen K. The annual incidence of DiGeorge/velocardiofacial syndrome. <span><span class="ref-journal">J Med Genet. </span>1998;<span class="ref-vol">35</span>:789–90.</span> [letter] [<a href="/pmc/articles/PMC1051442/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1051442</span></a>] [<a href="/pubmed/9733045" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9733045</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.devriendt.1996.349">Devriendt K, Swillen A, Fryns JP, Proesmans W, Gewillig M. Renal and urological tract malformations caused by a 22q11 deletion. <span><span class="ref-journal">J Med Genet. </span>1996;<span class="ref-vol">33</span>:349.</span> [letter] [<a href="/pmc/articles/PMC1050591/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1050591</span></a>] [<a href="/pubmed/8730297" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8730297</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.digilio.1999.137">Digilio MC, Marino B, Bagolan P, Giannotti A, Dallapiccola B. Microdeletion 22q11 and oesophageal atresia. <span><span class="ref-journal">J Med Genet. </span>1999;<span class="ref-vol">36</span>:137–9.</span> [<a href="/pmc/articles/PMC1734297/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734297</span></a>] [<a href="/pubmed/10051013" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10051013</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.dinulos.1998">Dinulos MB, Graf WD. DiGeorge syndrome and velocardiofacial syndrome. In: Gilman S, Goldstein GW, Waxman SG, eds. <em>Neurobase</em>. San Diego, CA: Arbor Press; 1998.</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.driscoll.1992.924">Driscoll DA, Budarf ML, Emanuel BS. A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11. <span><span class="ref-journal">Am J Hum Genet. </span>1992;<span class="ref-vol">50</span>:924–33.</span> [<a href="/pmc/articles/PMC1682598/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1682598</span></a>] [<a href="/pubmed/1349199" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1349199</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.driscoll.1995">Driscoll DA, Randall P, McDonald-McGinn DM, et al. Are 22q11 chromosomal deletions a major cause of isolated cleft palate? 52nd Annual Meeting. Tampa, FL: American Cleft Palate-Craniofacial Association; 1995.</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.driscoll.1993.813">Driscoll DA, Salvin J, Sellinger B, Budarf ML, McDonald-McGinn DM, Zackai EH, Emanuel BS. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. <span><span class="ref-journal">J Med Genet. </span>1993;<span class="ref-vol">30</span>:813–7.</span> [<a href="/pmc/articles/PMC1016560/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1016560</span></a>] [<a href="/pubmed/8230155" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8230155</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.eicher.2000.158">Eicher PS, McDonald-Mcginn DM, Fox CA, Driscoll DA, Emanuel BS, Zackai EH. Dysphagia in children with a 22q11.2 deletion: unusual pattern found on modified barium swallow. <span><span class="ref-journal">J Pediatr. </span>2000;<span class="ref-vol">137</span>:158–64.</span> [<a href="/pubmed/10931405" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10931405</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.fine.2005.461">Fine SE, Weissman A, Gerdes M, Pinto-Martin J, Zackai EH, McDonald-McGinn DM, Emanuel BS. Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome. <span><span class="ref-journal">J Autism Dev Disord. </span>2005;<span class="ref-vol">35</span>:461–70.</span> [<a href="/pmc/articles/PMC2814423/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2814423</span></a>] [<a href="/pubmed/16134031" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16134031</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.forbes.2007.179">Forbes BJ, Binenbaum G, Edmond JC, DeLarato N, McDonald-McGinn DM, Zackai EH. Ocular findings in the chromosome 22q11.2 deletion syndrome. <span><span class="ref-journal">J AAPOS. </span>2007;<span class="ref-vol">11</span>:179–82.</span> [<a href="/pubmed/17140829" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17140829</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.fryburg.1996.274">Fryburg JS, Lin KY, Golden WL. Chromosome 22q11.2 deletion in a boy with Opitz (G/BBB) syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">62</span>:274–5.</span> [<a href="/pubmed/8882786" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8882786</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.gennery.2002.422">Gennery AR, Barge D, O'Sullivan JJ, Flood TJ, Abinun M, Cant AJ. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. <span><span class="ref-journal">Arch Dis Child. </span>2002;<span class="ref-vol">86</span>:422–5.</span> [<a href="/pmc/articles/PMC1763000/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1763000</span></a>] [<a href="/pubmed/12023174" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12023174</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.giannotti.1994.303">Giannotti A, Digilio MC, Marino B, Mingarelli R, Dallapiccola B. Cayler cardiofacial syndrome and del 22q11: part of the CATCH22 phenotype. <span><span class="ref-journal">Am J Med Genet. </span>1994;<span class="ref-vol">53</span>:303.</span> [letter] [<a href="/pubmed/7856669" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7856669</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.gong.2001.e45">Gong W, Gottlieb S, Collins J, Blescia A, Dietz H, Goldmuntz E, McDonald-McGinn DM, Zackai EH, Emanuel BS, Driscoll DA, Budarf ML. Mutation analysis of TBX1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects. <span><span class="ref-journal">J Med Genet. </span>2001;<span class="ref-vol">38</span>:E45.</span> [<a href="/pmc/articles/PMC1734783/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734783</span></a>] [<a href="/pubmed/11748311" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11748311</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.gripp.1997.290">Gripp KW, McDonald-McGinn DM, Driscoll DA, Reed LA, Emanuel BS, Zackai EH. Nasal dimple as part of the 22q11.2 deletion syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1997;<span class="ref-vol">69</span>:290–2.</span> [<a href="/pubmed/9096759" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9096759</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.guionalmeida.1992.918">Guion-Almeida ML, Richieri-Costa A. CNS midline anomalies in the Opitz G/BBB syndrome: report on 12 Brazilian patients. <span><span class="ref-journal">Am J Med Genet. </span>1992;<span class="ref-vol">43</span>:918–28.</span> [<a href="/pubmed/1415340" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1415340</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.habel.2012.2665">Habel A, McGinn MJ 2nd, Zackai EH, Unanue N, McDonald-McGinn DM. Syndrome-specific growth charts for 22q11.2 deletion syndrome in Caucasian children. <span><span class="ref-journal">Am J Med Genet A. </span>2012 Nov;<span class="ref-vol">158A</span>:2665–71.</span> [<a href="/pubmed/22711268" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22711268</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.jawad.2001.715">Jawad AF, McDonald-Mcginn DM, Zackai E, Sullivan KE. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). <span><span class="ref-journal">J Pediatr. </span>2001;<span class="ref-vol">139</span>:715–23.</span> [<a href="/pubmed/11713452" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11713452</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.john.2009.939">John AS, McDonald-McGinn DM, Zackai EH, Goldmuntz E. Aortic root dilation in patients with 22q11.2 deletion syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:939–42.</span> [<a href="/pmc/articles/PMC4080309/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4080309</span></a>] [<a href="/pubmed/19353635" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19353635</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.jyonouchi.2009.e871">Jyonouchi S, McDonald-McGinn DM, Bale S, Zackai EH, Sullivan KE. CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features. <span><span class="ref-journal">Pediatrics. </span>2009;<span class="ref-vol">123</span>:e871–7.</span> [<a href="/pmc/articles/PMC4098848/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4098848</span></a>] [<a href="/pubmed/19403480" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19403480</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.kao.2004.29">Kao A, Mariani J, McDonald-McGinn DM, Maisenbacher MK, Brooks-Kayal AR, Zackai EH, Lynch DR. Increased prevalence of unprovoked seizures in patients with a 22q11.2 deletion. <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">129A</span>:29–34.</span> [<a href="/pubmed/15266612" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15266612</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.kapadia.2008.224">Kapadia CR, Kim YE, McDonald-McGinn DM, Zackai EH, Katz L. Parathyroid hormone reserve in 22q11.2 deletion syndrome. <span><span class="ref-journal">Genet Med. </span>2008;<span class="ref-vol">10</span>:224–8.</span> [<a href="/pubmed/18344713" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18344713</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.kates.2004.337">Kates WR, Burnette CP, Bessette BA, Folley BS, Strunge L, Jabs EW, Pearlson GD. Frontal and caudate alterations in velocardiofacial syndrome (deletion at chromosome 22q11.2). <span><span class="ref-journal">J Child Neurol. </span>2004;<span class="ref-vol">19</span>:337–42.</span> [<a href="/pubmed/15224707" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15224707</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.kawame.2001.892">Kawame H, Adachi M, Tachibana K, Kurosawa K, Ito F, Gleason MM, Weinzimer S, Levitt-Katz L, Sullivan K, McDonald-McGinn DM. Graves' disease in patients with 22q11.2 deletion. <span><span class="ref-journal">J Pediatr. </span>2001;<span class="ref-vol">139</span>:892–5.</span> [<a href="/pubmed/11743521" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11743521</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.keenan.1997.488">Keenan GF, Sullivan KE, McDonald-McGinn DM, Zackai EH. Arthritis associated with deletion of 22q11.2: more common than previously suspected. <span><span class="ref-journal">Am J Med Genet. </span>1997;<span class="ref-vol">71</span>:488.</span> [letter; comment] [<a href="/pubmed/9286462" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9286462</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.kelley.1982.197">Kelley RI, Zackai EH, Emanuel BS, Kistenmacher M, Greenberg F, Punnett HH. The association of the DiGeorge anomalad with partial monosomy of chromosome 22. <span><span class="ref-journal">J Pediatr. </span>1982;<span class="ref-vol">101</span>:197–200.</span> [<a href="/pubmed/7097410" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7097410</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.kilic.2003.e21">Kilic SS, Gurpinar A, Yakut T, Egeli U, Dogruyol H. Esophageal atresia and tracheo-esophageal fistula in a patient with Digeorge syndrome. <span><span class="ref-journal">J Pediatr Surg. </span>2003;<span class="ref-vol">38</span>:E21–3.</span> [<a href="/pubmed/12891520" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12891520</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.kirschner.2005">Kirschner RE. Palatal anomalies and velopharyngeal dysfunction associated with velo-cardio-facial syndrome. In: Murphy KC, Scambler PJ. <em>Velo-Cardio-Facial Syndrome: A Model for Understanding Microdeletion Disorders.</em> New York, NY: Cambridge University Press; 2005:83-104.</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.kobrynski.2007.1443">Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. <span><span class="ref-journal">Lancet. </span>2007;<span class="ref-vol">370</span>:1443–52.</span> [<a href="/pubmed/17950858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17950858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.krantz.1997.152">Krantz ID, Piccoli DA, Spinner NB. Alagille syndrome. <span><span class="ref-journal">J Med Genet. </span>1997;<span class="ref-vol">34</span>:152–7.</span> [<a href="/pmc/articles/PMC1050871/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1050871</span></a>] [<a href="/pubmed/9039994" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9039994</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.kurahashi.1996.1377">Kurahashi H, Nakayama T, Osugi Y, Tsuda E, Masuno M, Imaizumi K, Kamiya T, Sano T, Okada S, Nishisho I. Deletion mapping of 22q11 in CATCH22 syndrome: identification of a second critical region. <span><span class="ref-journal">Am J Hum Genet. </span>1996;<span class="ref-vol">58</span>:1377–81.</span> [<a href="/pmc/articles/PMC1915078/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1915078</span></a>] [<a href="/pubmed/8651317" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8651317</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.lacassie.1996.318">Lacassie Y, Arriaza MI. Letter to the editor. Opitz GBBB syndrome and the 22q11 deletion syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">62</span>:318.</span> [<a href="/pubmed/8882795" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8882795</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.levin.1982.227">Levin SE, Silverman NH, Milner S. Hypoplasia or absence of the depressor anguli oris muscle and congenital abnormalities, with special reference to the cardiofacial syndrome. <span><span class="ref-journal">S Afr Med J. </span>1982;<span class="ref-vol">61</span>:227–31.</span> [<a href="/pubmed/7058445" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7058445</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.levy.1995.2417">Levy A, Demczuk S, Aurias A, Depetris D, Mattei MG, Philip N. Interstitial 22q11 microdeletion excluding the ADU breakpoint in a patient with DiGeorge syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>1995;<span class="ref-vol">4</span>:2417–9.</span> [<a href="/pubmed/8634722" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8634722</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.lynch.1995.561">Lynch DR, McDonald-McGinn DM, Zackai EH, Emanuel BS, Driscoll DA, Whitaker LA, Fischbeck KH. Cerebellar atrophy in a patient with velocardiofacial syndrome. <span><span class="ref-journal">J Med Genet. </span>1995;<span class="ref-vol">32</span>:561–3.</span> [see comments] [<a href="/pmc/articles/PMC1050553/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1050553</span></a>] [<a href="/pubmed/7562973" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7562973</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.macdonald.1993.706">MacDonald MR, Schaefer GB, Olney AH, Tamayo M, Frias JL. Brain magnetic resonance imaging findings in the Opitz G/BBB syndrome: extension of the spectrum of midline brain anomalies. <span><span class="ref-journal">Am J Med Genet. </span>1993;<span class="ref-vol">46</span>:706–11.</span> [<a href="/pubmed/8362914" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8362914</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.matsuoka.1994.285">Matsuoka R, Takao A, Kimura M, Imamura S, Kondo C, Joh-o K, Ikeda K, Nishibatake M, Ando M, Momma K. Confirmation that the conotruncal anomaly face syndrome is associated with a deletion within 22q11.2. <span><span class="ref-journal">Am J Med Genet. </span>1994;<span class="ref-vol">53</span>:285–9.</span> [<a href="/pubmed/7856665" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7856665</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.mcdonaldmcginn.a">McDonald-McGinn D, Kohut A, Saitta S, Laskin R, Hacker A, Bale S, Aradhav S, Rosenfeld J, Shaffer L, Sullivan K, Emanuel B, Zackai E. Chromosome 22q11.2 "B-D" Deletion &#x02013; New Diagnosis or More of the Same? Platform Presentation. Washington, DC: American Society of Human Genetics Meeting; 2010a.</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.mcdonaldmcginn.1995.103">McDonald-McGinn DM, Driscoll DA, Bason L, Christensen K, Lynch D, Sullivan K, Canning D, Zavod W, Quinn N, Rome J. Autosomal dominant "Opitz" GBBB syndrome due to a 22q11.2 deletion. <span><span class="ref-journal">Am J Med Genet. </span>1995;<span class="ref-vol">59</span>:103–13.</span> [<a href="/pubmed/8849001" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8849001</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.mcdonaldmcginn.1996.525">McDonald-McGinn DM, Emanuel BS, Zackai EH. Autosomal dominant "Opitz" GBBB syndrome due to a 22q11.2 deletion. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">64</span>:525–6.</span> [<a href="/pubmed/8862635" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8862635</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.mcdonaldmcginn.2013.80">McDonald-McGinn DM, Fahiminiya S, Revil T, Nowakowska BA, Suhl J, Bailey A, Mlynarski E, Lynch DR, Yan AC, Bilaniuk LT, Sullivan KE, Warren ST, Emanuel BS, Vermeesch JR, Zackai EH, Jerome-Majewska LA. Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DS. <span><span class="ref-journal">J Med Genet. </span>2013;<span class="ref-vol">50</span>:80–90.</span> [<a href="/pmc/articles/PMC3585484/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3585484</span></a>] [<a href="/pubmed/23231787" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23231787</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.mcdonaldmcginn.1999.11">McDonald-McGinn DM, Kirschner R, Goldmuntz E, Sullivan K, Eicher P, Gerdes M, Moss E, Solot C, Wang P, Jacobs I, Handler S, Knightly C, Heher K, Wilson M, Ming JE, Grace K, Driscoll D, Pasquariello P, Randall P, Larossa D, Emanuel BS, Zackai EH. The Philadelphia story: the 22q11.2 deletion: report on 250 patients. <span><span class="ref-journal">Genet Couns. </span>1999;<span class="ref-vol">10</span>:11–24.</span> [<a href="/pubmed/10191425" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10191425</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.mcdonaldmcginn.b">McDonald-McGinn DM, Kohut T, Zackai EH. Deletion 22q11.2 (velo-cardio-facial syndrome/DiGeorge syndrome). In: Cassidy SB, Allanson JE, eds. <em>Management of Genetic Syndromes</em>. 3 ed. Hoboken, NJ: Wiley-Blackwell; 2010b:263-84.</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.mcdonaldmcginn.1997a.99">McDonald-McGinn DM, LaRossa D, Goldmuntz E, Sullivan K, Eicher P, Gerdes M, Moss E, Wang P, Solot C, Schultz P, Lynch D, Bingham P, Keenan G, Weinzimer S, Ming JE, Driscoll D, Clark BJ 3rd, Markowitz R, Cohen A, Moshang T, Pasquariello P, Randall P, Emanuel BS, Zackai EH. The 22q11.2 deletion: screening, diagnostic workup, and outcome of results; report on 181 patients. <span><span class="ref-journal">Genet Test. </span>1997a;<span class="ref-vol">1</span>:99–108.</span> [<a href="/pubmed/10464633" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10464633</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.mcdonaldmcginn.2004">McDonald-McGinn DM, Maisenbacher M, Ciprero K, Hoffman T, Catanzaro J, Armeli C, Goldmuntz E, Gleason M, Gillis L, Mascarenhas M, Porter B, Hedricks H, Nance M, Adzick A, Drummond D, Pasquariello P, Driscoll D, Emanuel B, Zackai EH. Warning: Hear Hoofbeats - Think Zebras in the 22q11.2 Deletion! Toronto, Ontario: American Society of Human Genetics 54th Annual Meeting; 2004.</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.mcdonaldmcginn.2005.242">McDonald-McGinn DM, Minugh-Purvis N, Kirschner RE, Jawad A, Tonnesen MK, Catanzaro JR, Goldmuntz E, Driscoll D, Larossa D, Emanuel BS, Zackai EH. The 22q11.2 deletion in African-American patients: an underdiagnosed population? <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">134</span>:242–6.</span> [<a href="/pmc/articles/PMC2810968/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2810968</span></a>] [<a href="/pubmed/15754359" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15754359</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.mcdonaldmcginn.2006.906">McDonald-McGinn DM, Reilly A, Wallgren-Pettersson C, Hoyme HE, Yang SP, Adam MP, Zackai EH, Sullivan KE. Malignancy in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:906–9.</span> [<a href="/pubmed/16532473" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16532473</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.mcdonaldmcginn.2001.23">McDonald-McGinn DM, Tonnesen MK, Laufer-Cahana A, Finucane B, Driscoll DA, Emanuel BS, Zackai EH. Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net! <span><span class="ref-journal">Genet Med. </span>2001;<span class="ref-vol">3</span>:23–9.</span> [<a href="/pubmed/11339373" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11339373</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.mcdonaldmcginn.2008.69">McDonald-McGinn DM, Zackai EH. Genetic counseling for the 22q11.2 deletion. <span><span class="ref-journal">Dev Disabil Res Rev. </span>2008;<span class="ref-vol">14</span>:69–74.</span> [<a href="/pubmed/18636638" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18636638</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.mcdonaldmcginn.1997b.247">McDonald-McGinn DM, Zackai EH, Low D. What's in a name? The 22q11.2 deletion. <span><span class="ref-journal">Am J Med Genet. </span>1997b;<span class="ref-vol">72</span>:247–9.</span> [<a href="/pubmed/9382154" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9382154</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.mcquade.1999.27">McQuade L, Christodoulou J, Budarf M, Sachdev R, Wilson M, Emanuel B, Colley A. Patient with a 22q11.2 deletion with no overlap of the minimal DiGeorge syndrome critical region (MDGCR). <span><span class="ref-journal">Am J Med Genet. </span>1999;<span class="ref-vol">86</span>:27–33.</span> [<a href="/pubmed/10440825" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10440825</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.ming.1997.210">Ming JE, McDonald-McGinn DM, Megerian TE, Driscoll DA, Elias ER, Russell BM, Irons M, Emanuel BS, Markowitz RI, Zackai EH. Skeletal anomalies and deformities in patients with deletions of 22q11. <span><span class="ref-journal">Am J Med Genet. </span>1997;<span class="ref-vol">72</span>:210–5.</span> [<a href="/pubmed/9382145" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9382145</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.moss.1995.a42">Moss E, Wang PP, McDonald-McGinn DM, et al.  Characteristic cognitive profile in patients with a 22q11 deletion: verbal IQ exceeds nonverbal IQ. <span><span class="ref-journal">Am J Hum Genet. </span>1995;<span class="ref-vol">57</span>:A42.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.murphy.1999.940">Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. <span><span class="ref-journal">Arch Gen Psychiatry. </span>1999;<span class="ref-vol">56</span>:940–5.</span> [<a href="/pubmed/10530637" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10530637</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.neri.1987.287">Neri G, Genuardi M, Natoli G, Costa P, Maggioni G. A girl with G syndrome and agenesis of the corpus callosum. <span><span class="ref-journal">Am J Med Genet. </span>1987;<span class="ref-vol">28</span>:287–91.</span> [<a href="/pubmed/3425610" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3425610</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.niklasson.2001.79">Niklasson L, Rasmussen P, Oskarsdottir S, Gillberg C. Neuropsychiatric disorders in the 22q11 deletion syndrome. <span><span class="ref-journal">Genet Med. </span>2001;<span class="ref-vol">3</span>:79–84.</span> [<a href="/pubmed/11339385" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11339385</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.odonnell.1997.1544">O'Donnell H, McKeown C, Gould C, Morrow B, Scambler P. Detection of an atypical 22q11 deletion that has no overlap with the DiGeorge syndrome critical region. <span><span class="ref-journal">Am J Hum Genet. </span>1997;<span class="ref-vol">60</span>:1544.</span> [letter] [<a href="/pmc/articles/PMC1716117/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1716117</span></a>] [<a href="/pubmed/9199579" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9199579</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.oskarsd_ttir.2005a.177">Oskarsd&#x000f3;ttir S, Belfrage M, Sandstedt E, Viggedal G, Uvebrant P. Disabilities and cognition in children and adolescents with 22q11 deletion syndrome. <span><span class="ref-journal">Dev Med Child Neurol. </span>2005a;<span class="ref-vol">47</span>:177–84.</span> [<a href="/pubmed/15739722" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15739722</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.oskarsd_ttir.2005b.146">Oskarsd&#x000f3;ttir S, Persson C, Eriksson BO, Fasth A. Presenting phenotype in 100 children with the 22q11 deletion syndrome. <span><span class="ref-journal">Eur J Pediatr. </span>2005b;<span class="ref-vol">164</span>:146–53.</span> [<a href="/pubmed/15565286" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15565286</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.oskarsd_ttir.2004.148">Oskarsd&#x000f3;ttir S, Vujic M, Fasth A. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. <span><span class="ref-journal">Arch Dis Child. </span>2004;<span class="ref-vol">89</span>:148–51.</span> [<a href="/pmc/articles/PMC1719787/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1719787</span></a>] [<a href="/pubmed/14736631" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14736631</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.patrone.1990.425">Patrone PM, Chatten J, Weinberg P. Neuroblastoma and DiGeorge anomaly. <span><span class="ref-journal">Pediatr Pathol. </span>1990;<span class="ref-vol">10</span>:425–30.</span> [<a href="/pubmed/2161524" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2161524</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.ricchetti.2004.1751">Ricchetti ET, States L, Hosalkar HS, Tamai J, Maisenbacher M, McDonald-McGinn DM, Zackai EH, Drummond DS. Radiographic study of the upper cervical spine in the 22q11.2 deletion syndrome. <span><span class="ref-journal">J Bone Joint Surg Am. </span>2004;<span class="ref-vol">86-A</span>:1751–60.</span> [<a href="/pubmed/15292424" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15292424</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.sanklecha.1992.147">Sanklecha M, Kher A, Bharucha BA. Asymmetric crying facies: the cardiofacial syndrome. <span><span class="ref-journal">J Postgrad Med. </span>1992;<span class="ref-vol">38</span>:147–8,150.</span> [<a href="/pubmed/1303422" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1303422</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.scattone.2003.323">Scattone A, Caruso G, Marzullo A, Piscitelli D, Gentile M, Bonadonna L, Balducci G, Digilio MC, Jenkner A, Camassei FD, Boldrini R, Nazzaro P, Pollice L, Serio G. Neoplastic disease and deletion 22q11.2: a multicentric study and report of two cases. <span><span class="ref-journal">Pediatr Pathol Mol Med. </span>2003;<span class="ref-vol">22</span>:323–41.</span> [<a href="/pubmed/14692228" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14692228</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.scambler.1991.201">Scambler PJ, Carey AH, Wyse RK, Roach S, Dumanski JP, Nordenskjold M, Williamson R. Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome. <span><span class="ref-journal">Genomics. </span>1991;<span class="ref-vol">10</span>:201–6.</span> [<a href="/pubmed/2045103" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2045103</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.shprintzen.1992.141">Shprintzen RJ, Goldberg R, Golding-Kushner KJ, Marion RW. Late-onset psychosis in the velo-cardio-facial syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1992;<span class="ref-vol">42</span>:141–2.</span> [letter] [<a href="/pubmed/1308357" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1308357</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.silengo.1986.481">Silengo MC, Bell GL, Biagioli M, Guala A, Bianco R, Strandoni P, De Sario PN, Franceschini P. Asymmetric crying facies with microcephaly and mental retardation. An autosomal dominant syndrome with variable expressivity. <span><span class="ref-journal">Clin Genet. </span>1986;<span class="ref-vol">30</span>:481–4.</span> [<a href="/pubmed/3815881" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3815881</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.smith.1998.415">Smith CA, Driscoll DA, Emanuel BS, McDonald-McGinn DM, Zackai EH, Sullivan KE. Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). <span><span class="ref-journal">Clin Diagn Lab Immunol. </span>1998;<span class="ref-vol">5</span>:415–7.</span> [<a href="/pmc/articles/PMC104536/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC104536</span></a>] [<a href="/pubmed/9606003" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9606003</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.solot.1998">Solot C, Gerdes M, McDonald-McGinn D, et al. Developmental profiles in a pre-school population with 22q11 deletion. Baltimore, MD: American Cleft Palate-Craniofacial Association 55th Annual Meeting and Conference Symposium; 1998.</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.stoller.2005.885">Stoller JZ, Epstein JA. Identification of a novel nuclear localization signal in Tbx1 that is deleted in DiGeorge syndrome patients harboring the 1223delC mutation. <span><span class="ref-journal">Hum Mol Genet. </span>2005;<span class="ref-vol">14</span>:885–92.</span> [<a href="/pubmed/15703190" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15703190</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.sullivan.2004.505">Sullivan KE. The clinical, immunological, and molecular spectrum of chromosome 22q11.2 deletion syndrome and DiGeorge syndrome. <span><span class="ref-journal">Curr Opin Allergy Clin Immunol. </span>2004;<span class="ref-vol">4</span>:505–12.</span> [<a href="/pubmed/15640691" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15640691</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.sullivan.1998.141">Sullivan KE, Jawad AF, Randall P, Driscoll DA, Emanuel BS, McDonald-McGinn DM, Zackai EH. Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes. <span><span class="ref-journal">Clin Immunol Immunopathol. </span>1998;<span class="ref-vol">86</span>:141–6.</span> [<a href="/pubmed/9473376" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9473376</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.sullivan.1999.906">Sullivan KE, McDonald-McGinn D, Driscoll DA, Emanuel BS, Zackai EH, Jawad AF. Longitudinal analysis of lymphocyte function and numbers in the first year of life in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). <span><span class="ref-journal">Clin Diagn Lab Immunol. </span>1999;<span class="ref-vol">6</span>:906–11.</span> [<a href="/pmc/articles/PMC95796/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC95796</span></a>] [<a href="/pubmed/10548584" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10548584</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.sullivan.1997.430">Sullivan KE, McDonald-McGinn DM, Driscoll DA, Zmijewski CM, Ellabban AS, Reed L, Emanuel BS, Zackai EH, Athreya BH, Keenan G. Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome). <span><span class="ref-journal">Arthritis Rheum. </span>1997;<span class="ref-vol">40</span>:430–6.</span> [<a href="/pubmed/9082929" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9082929</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.sundaram.2007.2016">Sundaram UT, McDonald-McGinn D, Huff D, Emanuel B, Zackai E, Driscoll D, Bodurtha J. Primary amenorrhea and absent uterus in the 22q11.2 deletion syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:2016–8.</span> [<a href="/pmc/articles/PMC2810967/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2810967</span></a>] [<a href="/pubmed/17676598" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17676598</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.swillen.1999.230">Swillen A, Vandeputte L, Cracco J, Maes B, Ghesqui&#x000e8;re P, Devriendt K, Fryns JP. Neuropsychological, learning and psychosocial profile of primary school aged children with the velo-cardio-facial syndrome (22q11 deletion): evidence for a nonverbal learning disability? <span><span class="ref-journal">Child Neuropsychol. </span>1999;<span class="ref-vol">5</span>:230–41.</span> [<a href="/pubmed/10925707" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10925707</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.thomas.1997.253">Thomas JA, Graham JM Jr. Chromosomes 22q11 deletion syndrome: an update and review for the primary pediatrician. <span><span class="ref-journal">Clin Pediatr (Phila). </span>1997;<span class="ref-vol">36</span>:253–66.</span> [<a href="/pubmed/9152551" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9152551</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.vorstman.2006.1104">Vorstman JA, Morcus ME, Duijff SN, Klaassen PW, Heineman-de Boer JA, Beemer FA, Swaab H, Kahn RS, van Engeland H. The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. <span><span class="ref-journal">J Am Acad Child Adolesc Psychiatry. </span>2006;<span class="ref-vol">45</span>:1104–13.</span> [<a href="/pubmed/16926618" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16926618</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.wang.1998.342">Wang PP, Solot C, Moss EM, Gerdes M, McDonald-McGinn DM, Driscoll DA, Emanuel BS, Zackai EH. Developmental presentation of 22q11.2 deletion (DiGeorge/velocardiofacial syndrome). <span><span class="ref-journal">J Dev Behav Pediatr. </span>1998;<span class="ref-vol">19</span>:342–5.</span> [<a href="/pubmed/9809264" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9809264</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.weinzimer.1998.929">Weinzimer SA, McDonald-McGinn DM, Driscoll DA, Emanuel BS, Zackai EH, Moshang T Jr. Growth hormone deficiency in patients with 22q11.2 deletion: expanding the phenotype. <span><span class="ref-journal">Pediatrics. </span>1998;<span class="ref-vol">101</span>:929–32.</span> [<a href="/pubmed/9565428" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9565428</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.wilson.1993.852">Wilson DI, Burn J, Scambler P, Goodship J. DiGeorge syndrome: part of CATCH 22. <span><span class="ref-journal">J Med Genet. </span>1993;<span class="ref-vol">30</span>:852–6.</span> [<a href="/pmc/articles/PMC1016569/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1016569</span></a>] [<a href="/pubmed/8230162" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8230162</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.wilson.1992.957">Wilson DI, Cross IE, Goodship JA, Brown J, Scambler PJ, Bain HH, Taylor JF, Walsh K, Bankier A, Burn J, Wolstenholme J. A prospective cytogenetic study of 36 cases of DiGeorge syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>1992;<span class="ref-vol">51</span>:957–63.</span> [<a href="/pmc/articles/PMC1682842/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1682842</span></a>] [<a href="/pubmed/1415264" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1415264</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.wilson.1994.a169">Wilson DI, Cross IE, Wren C, et al.  Minimum prevalence of chromosome 22q11 deletions. <span><span class="ref-journal">Am J Hum Genet. </span>1994;<span class="ref-vol">55</span>:A169.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.wu.2002.2564">Wu HY, Rusnack SL, Bellah RD, Plachter N, McDonald-McGinn DM, Zackai EH, Canning DA. Genitourinary malformations in chromosome 22q11.2 deletion. <span><span class="ref-journal">J Urol. </span>2002;<span class="ref-vol">168</span>:2564–5.</span> [<a href="/pubmed/12441983" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12441983</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.wulfsberg.1996.317">Wulfsberg EA, Leana-Cox J, Neri G. What's in a name? Chromosome 22q abnormalities and the DiGeorge, velocardiofacial, and conotruncal anomalies face syndromes. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">65</span>:317–9.</span> [see comments] [<a href="/pubmed/8923942" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8923942</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.yagi.2003.1366">Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, Ichida F, Joo K, Kimura M, Imamura S, Kamatani N, Momma K, Takao A, Nakazawa M, Shimizu N, Matsuoka R. Role of TBX1 in human del22q11.2 syndrome. <span><span class="ref-journal">Lancet. </span>2003;<span class="ref-vol">362</span>:1366–73.</span> [<a href="/pubmed/14585638" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14585638</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.yamagishi.1999.1158">Yamagishi H, Garg V, Matsuoka R, Thomas T, Srivastava D. A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects. <span><span class="ref-journal">Science. </span>1999;<span class="ref-vol">283</span>:1158–61.</span> [<a href="/pubmed/10024240" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10024240</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gr_22q11deletion.REF.yan.1998.41">Yan W, Jacobsen LK, Krasnewich DM, Guan XY, Lenane MC, Paul SP, Dalwadi HN, Zhang H, Long RT, Kumra S, Martin BM, Scambler PJ, Trent JM, Sidransky E, Ginns EI, Rapoport JL. Chromosome 22q11.2 interstitial deletions among childhood-onset schizophrenics and "multidimensionally impaired". <span><span class="ref-journal">Am J Med Genet. </span>1998;<span class="ref-vol">81</span>:41–3.</span> [<a href="/pubmed/9514586" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9514586</span></a>]</div></li></ul></div></div><div id="gr_22q11deletion.Chapter_Notes"><h2 id="_gr_22q11deletion_Chapter_Notes_">Chapter Notes</h2><div id="gr_22q11deletion.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>28 February 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>16 December 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 July 2003 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 September 1999 (me) Review posted live</div></li><li class="half_rhythm"><div>7 August 1998 (dmm) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1523</span><span class="label">PMID: <a href="/pubmed/20301696" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301696</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cah/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/dupl22q11/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1523&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1523/?report=reader">PubReader</a></li><li><a href="/books/NBK1523/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1523" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1523" style="display:none" title="Cite this Page"><div class="bk_tt">McDonald-McGinn DM, Emanuel BS, Zackai EH. 22q11.2 Deletion Syndrome. 1999 Sep 23 [Updated 2013 Feb 28]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1523/pdf/Bookshelf_NBK1523.pdf">PDF version of this page</a> (356K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#gr_22q11deletion.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#gr_22q11deletion.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#gr_22q11deletion.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#gr_22q11deletion.Clinical_Characteristic" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#gr_22q11deletion.Genetically_Related_Dis" ref="log$=inpage&amp;link_id=inpage">Genetically Related Disorders</a></li><li><a href="#gr_22q11deletion.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#gr_22q11deletion.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#gr_22q11deletion.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#gr_22q11deletion.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#gr_22q11deletion.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#gr_22q11deletion.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#gr_22q11deletion.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=9993[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DGCR2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=54487[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DGCR8</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8220[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ESS2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8214[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DGCR6</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6899[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TBX1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=23384[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SPECC1L</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1462138" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1462138" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1462138" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1462138" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31145570" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Apert Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Apert Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wenger TL, Hing AV, Evans KN. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301487" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Smith-Magenis Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Smith-Magenis Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Smith ACM, Boyd KE, Brennan C, Charles J, Elsea SH, Finucane BM, Foster R, Gropman A, Girirajan S, Haas-Givler B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301534" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PAX6</i>-Related Aniridia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PAX6</i>-Related Aniridia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moosajee M, Hingorani M, Moore AT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/9113966" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Detection of a 22q11.2 deletion in cardiac patients suggests a risk for velopharyngeal incompetence.</a><span class="source">[Pediatrics. 1997]</span><div class="brieflinkpop offscreen_noflow">Detection of a 22q11.2 deletion in cardiac patients suggests a risk for velopharyngeal incompetence.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">McDonald-McGinn DM, Driscoll DA, Emanuel BS, Goldmuntz E, Clark BJ 3rd, Solot C, Cohen M, Schultz P, LaRossa D, Randall P, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pediatrics. 1997 May; 99(5):E9. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25523123" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].</a><span class="source">[Encephale. 2015]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Demily C, Rossi M, Schneider M, Edery P, Leleu A, d'Amato T, Franck N, Eliez S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Encephale. 2015 Jun; 41(3):266-73. Epub 2014 Dec 16.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301696" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301696" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041722dde0891169206a82">22q11.2 Deletion Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">22q11.2 Deletion Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:12:50-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE89B3D4E0413EF10000000001B700C6&amp;ncbi_session=CE89B3D4E0417211_0439SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1523%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1523&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1523/&amp;ncbi_pagename=22q11.2 Deletion Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE89B3D4E0417211_0439SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>